MDR_REPORT_KEY|MDR_TEXT_KEY|TEXT_TYPE_CODE|PATIENT_SEQUENCE_NUMBER|DATE_REPORT|FOI_TEXT|BRAND_NAME|CATALOG_NUMBER|DATE_RECEIVED|DATE_REMOVED_FLAG|DATE_RETURNED_TO_MANUFACTURER|DEVICE_AGE_TEXT|DEVICE_AVAILABILITY|DEVICE_EVALUATED_BY_MANUFACTUR|DEVICE_EVENT_KEY|DEVICE_OPERATOR|DEVICE_REPORT_PRODUCT_CODE|DEVICE_SEQUENCE_NO|EXPIRATION_DATE_OF_DEVICE|GENERIC_NAME|IMPLANT_FLAG|LOT_NUMBER|MANUFACTURER_D_ADDRESS_1|MANUFACTURER_D_ADDRESS_2|MANUFACTURER_D_CITY|MANUFACTURER_D_COUNTRY_CODE|MANUFACTURER_D_NAME|MANUFACTURER_D_POSTAL_CODE|MANUFACTURER_D_STATE_CODE|MANUFACTURER_D_ZIP_CODE|MANUFACTURER_D_ZIP_CODE_EXT|MODEL_NUMBER|OTHER_ID_NUMBER|filter
6233845|68040031|D|1||PHYSICIAN REPORTS SLIGHT AMOUNT OF EFFUSION AROUND THE RIGHT IMPLANT AND SOME HARDENING WITH SOME CAPSULAR CONTRACTURE GRADE III DISTORTING THE BREAST AND GOES ON TO STATE FAIRLY THICK CAPSULE WITH SOME FLUID WITHIN IT ALTHOUGH THE FLUID WAS CLEAR AND NOT IN ANY WAY MILKY A TOTAL CAPSULECTOMY WAS CARRIED OUT AND SENT FOR HISTOLOGY HISTOPATHOLOGY REPORTS THE SPECIMEN COMPRISES A FIBROUS CAPSULE WITH ADHESIONS AND IRREGULARITY OVER THE EXTERNAL SURFACE AS WELL AS SECTIONS OF THE CAPSULE SHOW FIBROUS TISSUE WITH PATCHY MIXED INFLAMMATION HISTOPATHOLOGY CONFIRMS CD30+ AND ALK- THIS IS NOW A CONFIRMED CASE OF ALCL|STYLE 110 SILICONE GEL FILLED BREAST IMPLANT|UNK STYLE 110|01/09/2017|||DA|N|R||0HP|FTR|1.0||PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||NI|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN (COSTA RICA)|||||||True
6247187|66742202|D|1||ADDITIONAL INFORMATION RECEIVED FROM THE HEALTH PROFESSIONAL REGARDING THE EVENT IN THE MRI REPORT DATED B6 2016 ADDITIONAL REPORTED EVENT OF IMPLANT SURROUNDED BY A LARGE COLLECTION OF FLUID PATHOLOGY RESULTS FROM B6 2016 REVEALED LEFT PERIPROSTHETIC CAPSULE ANAPLASTIC LARGE CELL LYMPHOMA ASSOCIATED WITH BREAST IMPLANT PATHOLOGY SHOWS ALCL MARKERS OF CD30+ AND ALK- PHYSICIAN ADDITIONALLY REPORTED EVENTS OF PAIN AND A FEELING OF LOCALIZED INFLAMMATION AROUND THE IMPLANT THE EVENT OF PAIN WILL BE NOT DEVICE RELATED AS IT IS A SECONDARY SYMPTOM TO OTHER REPORTED EVENTS|STYLE 410 COHESIVE SILICONE GEL FILLED BREAST IMPLANT|27-MX115-290|01/12/2017|||DA|N|R||0HP|FTR|1.0|09/04/2011|PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||1321464|KILBRIDE INDUSTRIAL ESTATE||ARKLOW, COUNTY WICKLOW||ALLERGAN (ARKLOW)|||||||True
6559362|74887821|D|1||PHYSICIAN REPORTED CASE OF LYMPHOMA ALCL PAIN RUPTURE LARGE SEROMA PRESENT FOR 2 YEARS AND CAPSULAR CONTRACTURE BAKER GRADE II CD30+ AND ALK- CONFIRMED MICROSCOPIC ANALYSIS FOUND CHRONIC INFLAMMATION AROUND A CAVITATION PATIENT HAD A LEFT SIDE CAPSULECTOMY WITH IMPLANT REMOVAL AND REPLACEMENT THESE EVENTS OCCURRED ON THE LEFT SIDE|INSPIRA TEXTURED SILICONE GEL FILLED BREAST IMPLANT|N-TRM445|05/10/2017||||N|R||0HP|FTR|1.0|10/11/2016|PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||2183997|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN (COSTA RICA)|||||||True
6744780|81082640|D|1||PHYSICIAN REPORTED LATE SEROMA IN IMPLANT BEARING WAS FOUND PHYSICIAN REPORTED A CASE OF ALCL CONFIRMED VIA CYTOLOGY OF FLUID IN THE IMPLANT CAPSULE ON THE LEFT SIDE CD30+ HAS BEEN CONFIRMED BUT ALL PATHOLOGICAL MARKERS HAVE NOT BEEN CONFIRMED EVENT WILL BE REPORTED AS LYMPHOMA TREATMENT UNKNOWN|INSPIRA TEXTURED SILICONE GEL FILLED BREAST IMPLANT|N-TSM520|07/26/2017||||N|R||0HP|FTR|1.0|10/04/2016|PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||2180982|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN (COSTA RICA)|||||||True
6247063|73823203|D|1||ADDITIONAL INFORMATION RECEIVED FROM HEALTHCARE PROFESSIONAL CONFIRMING EVENT IS AGAINST THE LEFT SIDE DEVICE CYTOLOGICAL MARKERS ALK- AND CD30+ HAVE BEEN REPORTED THIS IS A CONFIRMED CASE OF ALCL PHYSICIAN ADDITIONALLY REPORTED EVENT OF CAPSULAR CONTRACTURE AT PRESENTATION BAKER GRADE UNKNOWN|UNK MAMMARY IMPLANT|UNK MAMMARY IMPLANT|01/12/2017||||*|*||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||NI|||||UNKNOWN MANUFACTURER|||||||True
6247063|73823203|D|1||ADDITIONAL INFORMATION RECEIVED FROM HEALTHCARE PROFESSIONAL CONFIRMING EVENT IS AGAINST THE LEFT SIDE DEVICE CYTOLOGICAL MARKERS ALK- AND CD30+ HAVE BEEN REPORTED THIS IS A CONFIRMED CASE OF ALCL PHYSICIAN ADDITIONALLY REPORTED EVENT OF CAPSULAR CONTRACTURE AT PRESENTATION BAKER GRADE UNKNOWN|INSPIRA TEXTURED SILICONE GEL FILLED BREAST IMPLANT|N-TSLP280|01/12/2017|||DA|*|*||0HP|FTR|1.0|05/27/2015|PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||1845063|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN (COSTA RICA)|||||||True
6434492|70859691|D|1||HEALTHCARE PROFESSIONAL REPORTED LEFT SIDE SWELLING AND FLUID COLLECTION PATHOLOGY ADDITIONALLY PROVIDES THE EVENT OF Â¿UNSPECIFIED LUMP IN BREASTÂ¿ PATHOLOGICAL MARKERS ALK- AND CD30+ CONFIRMING LYMPHOMA ALCL HAVE BEEN RECEIVED|STYLE 410 COHESIVE SILICONE GEL FILLED BREAST IMPLANT|FF-410535|03/24/2017||||N|R||0HP|FTR|1.0||PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||2493185|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN (COSTA RICA)|||||||True
6544056|74409596|D|1||PHYSICIAN REPORTED EVENT OF LEFT SIDE ALCL TO B6 CD30+ MARKER HAS BEEN CONFIRMED PHYSICIAN REPORTED EVENTS OF PAIN LOSS OF 10 KG IN 1 YEAR RECURRENT LYMPHORREA INCREASE IN VOLUME TIGHTENING PERIPHERAL INFLAMMATION FIBRINOID NECROSIS AXILLARY ADENOPATHY ABUNDANT INTRACAPSULAR EFFUSION MASS AND ADENOFIBROMA PHYSICIAN ADDITIONALLY REPORTED THERE IS HYPERVASCULAR TISSUE THICKENING VISIBLE BY THE QUASI-CIRCUMFERENTIAL CAPSULE BUT PREDOMINANT IN INFERIOR-INTERNAL AND SUPERIOR-EXTERNAL PROJECTION THIS ALCL CASE WILL BE CAPTURED AS LYMPHOMA AS ALK NEGATIVE MARKER WAS NOT CONFIRMED DEVICE WAS EXPLANTED|INSPIRA TEXTURED SILICONE GEL FILLED BREAST IMPLANT|TRM310|05/04/2017||||N|R||0HP|FTR|1.0|09/14/2011|PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||1327562|KILBRIDE INDUSTRIAL ESTATE||ARKLOW, COUNTY WICKLOW||ALLERGAN (ARKLOW)|||||||True
6275633|65693785|D|1||PT HAD MCGHAN 363LF SALINE FILLED IMPLANTS PLACED ON B6 2016 PRESENTED WITH LARGE RIGHT BREAST SEROMA ON B6 2016 ULTRASOUND GUIDED ASPIRATION OF SEROMA PERFORMED ON B6 2016 AFTER ULTRASOUND AND MRI SHOWED LARGE LOCULATED RIGHT BREAST FLUID COLLECTION ASPIRATED FLUID SHOWED CD30+ AND ALK1 - CELLS LEADING TO THE DIAGNOSIS OF ALCL SHE HAD BILATERAL CAPSULECTOMIES AND REMOVAL OF IMPLANTS ON B6 2017 PATHOLOGY DID NOT REVEAL ANY EXTENSION OF THE ALCL INTO THE CAPSULAR SHE IS CURRENTLY BEING WORKED UP BY OUR ONCOLOGISTS WERE AS WELL AS OUR GENETICISTS|MCGHAN 363 LF||01/23/2017||||*|*||I|FWM|2.0||SALINE FILLED BREAST IMPLANTS||1262358|||||MCGHAN|||||363LF-300||True
6275633|65693785|D|1||PT HAD MCGHAN 363LF SALINE FILLED IMPLANTS PLACED ON B6 2016 PRESENTED WITH LARGE RIGHT BREAST SEROMA ON B6 2016 ULTRASOUND GUIDED ASPIRATION OF SEROMA PERFORMED ON B6 2016 AFTER ULTRASOUND AND MRI SHOWED LARGE LOCULATED RIGHT BREAST FLUID COLLECTION ASPIRATED FLUID SHOWED CD30+ AND ALK1 - CELLS LEADING TO THE DIAGNOSIS OF ALCL SHE HAD BILATERAL CAPSULECTOMIES AND REMOVAL OF IMPLANTS ON B6 2017 PATHOLOGY DID NOT REVEAL ANY EXTENSION OF THE ALCL INTO THE CAPSULAR SHE IS CURRENTLY BEING WORKED UP BY OUR ONCOLOGISTS WERE AS WELL AS OUR GENETICISTS|MCGHAN 363 LF||01/23/2017||||Y|*||0HP|FWM|1.0||SALINE FILLED BREAST IMPLANTS||1157904|||||MCGHAN|||||363LF-300||True
2149068|2071941|D|1||THE PATIENT HAD AUGMENTATION SURGERY IMPLANT DATE AND DEVICE INFORMATION UNKNOWN AT THIS TIME HOWEVER SHE DID HAVE EXPLANT SURGERY JANUARY 2000 AND WAS REPLACED WITH 468 TEXTURED SALINE IMPLANT THE PATIENT PRESENTS WITH LEFT SIDE SWELLING AND ENLARGEMENT A COMPLETE CAPSULECTOMY WITH IMPLANT REMOVAL WAS PERFORMED ON B6 2011 CYTOLOGY WAS PERFORMED ON THE SEROMA CYTOLOGY RESULTS SHOWS CD30+ ALK- A CT SCAN OF CHEST ABDOMEN AND PELVIS WAS ALSO CARRIED OUT AND WAS NEGATIVE FOR DISEASE AT THE TIME OF THIS REPORT THERE IS NO PLAN FOR CHEMOTHERAPY OR RADIATION TREATMENT AN ONGOING INVESTIGATION IS BEING CARRIED OUT ANY NEW INFORMATION WILL BE UPDATED AND FORWARDED ON ACCORDINGLY|STYLE 468 SALINE FILLED BREAST IMPLANT|468-380|06/13/2011|||DA|N|R||0HP|FWM|1.0|12/19/2003|nan||548477|||GOLETA, NE|US|ALLERGAN||CA|||||True
2348522|61100521|N|1||MEDWATCH SUBMITTED TO THE FDA ON 07162015 ADVERSE EVENT OF ALCL WAS REPORTED PREVIOUSLY BUT AS THERE IS NO PATHOLOGY OR FOLLOW-UP CONFIRMING CD30+ OR ALK- THE EVENT WILL REMAIN REPORTABLE AS LYMPHOMA|STYLE 68 SALINE FILLED BREAST IMPLANT|68-390|09/30/2011|||DA|N|R||0HP|FWM|1.0|07/30/2010|nan||1316501|||GOLETA|US|ALLERGAN||CA|||||True
2076644|2025896|D|1||SALES REPRESENTATIVE CALLED TO REPORT A CASE OF ALCL HE REPORTED THAT THE PATIENT HAD A HISTORY OF LEFT BREAST CANCER 17-18 YEARS AGO AND HAD UNDERGONE A BILATERAL MASTECTOMY THE RIGHT SIDE WAS FOR PROPHYLACTIC PURPOSES THE PATIENT HAD ALLERGAN TISSUE EXPANDERS PLACED AND ONCE EXPANSION WAS COMPLETE HAD 168 DEVICES IMPLANTED HOWEVER 3-4 YEARS AGO THE PATIENT HAD REMOVAL AND REPLACEMENT OF THE 168 TO A 68 DEVICE AT THIS TIME THE REASON FOR REPLACEMENT IS UNKNOWN IN B6 2011 THE PATIENT PRESENTED WITH RIGHT SIDE REDNESS AND EDEMA A DRAIN WAS PLACED AND FLUID WAS SENT TO THE LAB FOR ANALYSIS THE CYTOLOGY WAS ALCL+ THE SURGEON IS PLANNING ON A LYMPH NODE BIOPSY PENDING THE REMAINDER OF THE CYTOLOGY ADDITIONAL INFORMATION WAS THEN REQUESTED BY THE HEALTHCARE PROFESSIONAL FOR CLARIFICATION MEDICAL RECORDS WERE FORWARDED THAT DATE BACK TO B6 1987 WHEN THE PATIENT WAS ORIGINALLY DIAGNOSED WITH LEFT BREAST INTRADUCTAL CARINOMA THE PATIENT HAD IMPLANTED A DOW-CORNING TISSUE EXPANDER 500 CC DEVICE PLACED FILLED WITH 60 CC OF SALINE ON B6 1988 THE PATIENT RETURNED TO THE OPERATING ROOM FOR FIRST STAGE RECONSTRUCTION ON THE RIGHT SIDE A DOW-CORNING TISSUE EXPANDER 600CC TISSUE EXPANDER WAS PLACED AND FILLED TO 180CC ON B6 1988 BILATERAL SECOND STAGE RECONSTRUCTION WAS CARRIED OUT THE TISSUE EXPANDERS WERE REMOVED AND SURGITEK HIGH PROFILE RECONSTRUCTIVE IMPLANTS WERE PLACED CONTAINING 200CC OF GEL AND 50CC OF SALINE IN THE CENTRAL COLUMN THE TOTAL VOLUMES WERE 250CC ON THE RIGHT AND 270CC ON THE LEFT THE PATIENT WAS TAKEN BACK TO THE OPERATING ROOM ON B6 1994 FOR A RIGHT RUPTURED BREAST IMPLANT AFTER A RECENT MRI REVEALS BILATERAL IMPLANT ABNORMALITIES ONCE THE INCISION WAS MADE THE SILICONE WAS ENCOUNTERED IT SHOULD BE NOTED THAT WAS NOT TYPICAL COHESIVE GEL THE FLUID WAS THE CONSISTENCY OF HONEY OR AUTOMOBILE OIL IT FLOWED FREELY MCGHAN SALINE FILLED TEXTURED IMPLANTS 168 WERE EMPLOYED ON BOTH SIDES 27-168-271 B4 ON THE LEFT AND 27-168-241 B4 ON THE RIGHT ON B6 2011 THE PATIENT HAD A LEFT IMPLANT FAILURE A CAPSULECTOMY AND IMPLANT REMOVAL AND REPLACEMENT WAS PERFORMED DEVICE B4 27-168-271 WAS IMPLANTED ON THE LEFT SIDE THE PATIENT RETURNS IN B6 2011 WITH COMPLAINTS OF RIGHT SIDE SPONTANEOUS EXPANSION THAT BEGAN ABOUT ONE MONTH PRIOR SHE WAS AFEBRILE AND THERE WAS NO REDNESS PRESENT THIS REPRESENTED A SEROMA HOWEVER THIS HAS NOT RESOLVED TO ANY SIGNIFICANT DEGREE IN THE PAST FOUR WEEKS IT IS THEREFORE ELECTED AT THIS TIME TO EXPLORE THE AREA OBTAIN CYTOLOGY AND CULTURES AND PLACE A DRAIN THE CAPSULE WAS WINDOWED AND YELLOW FLUID WAS ENCOUNTERED IT WAS ASPIRATED FOR CYTOLOGY AEROBIC AND ANAEROBIC CULTURES WERE OBTAINED THE MCGHAN IMPLANT WAS ENCOUNTERED BUT NOT REMOVED FROM THE WOUND THERE WAS NO OVERT ABNORMALITY ON ITS SURFACE PATHOLOGY RETURNED CONFIRMS CD30+ CD45 SUBSET CD4 CD25 AND VIMENTIN ALK - |STYLE 168 SALINE FILLED BREAST IMPLANT|168-240|04/12/2011|||DA|N|R||0HP|FWM|1.0|09/01/1997|nan||2-507710|||GOLETA|US|ALLERGAN||CA|||||True
2025987|1914162|D|1||HEALTH PROFESSIONAL INITIALLY REPORTS PATIENT HAD HISTORY OF PREEXISTING BREAST CANCER WITH RECONSTRUCTION SURGERY BILATERAL TISSUE EXPANDERS AND MCGHAN SALINE TEXTURED IMPLANTS PLACED THE PATIENT PRESENTED WITH SWELLING OF LEFT BREAST SIX YEARS POST RECONSTRUCTION SALINE DEVICES EXPLANTED PER PATIENTS REQUEST AND EXCHANGED WITH ALLERGAN SILICONE SMOOTH DEVICES FLUID SENT FOR PATHOLOGYCYTOLOGY OPERATIVE NOTE DESCRIBE FLUID AS MODERATE BROWN LIQUID OLD BLOOD SENT TO CYTOLOGY AND THE RESULTS SHOWED CD30+ ALK- LEFT SEROMA CYTOLOGY DIAGNOSED AS ANAPLASTIC LARGE CELL LYMPHOMA NO CHEMOTHERAPY OR RADIATION THERAPY DONE THE DEVICE HAS BEEN EXPLANTED BUT THE DEVICE HAS NOT BEEN RETURNED TO ALLERGAN FOR ANALYSIS PATIENT IS DOING WELL IS SCHEDULED FOR A FOLLOW-UP ULTRA-SOUND AND CT SCAN AND IS BEING FOLLOWED BY AN ONCOLOGIST|STYLE 20 SILICONE GEL FILLED BREAST IMPLANT|20-500|03/16/2011|||DA|N|R||0HP|FTR|1.0||nan||NI|||GOLETA|US|ALLERGAN||CA|||||True
2261241|2158948|D|1||HEALTHCARE PROFESSIONAL REPORTS A CASE OF ALCL PAIN AND SEROMA VIA VOLUNTARY FORM B4 ADDL INFO GATHERED FROM THE SURGEONS OFFICE THE PT PRESENTS WITH COMPLAINTS OF PAIN ITCHING AND SWELLING OF THE LEFT BREAST A MAMMOGRAMSONOGRAM REVEALED CIRCUMFERENTIAL FLUID COLLECTION SURROUNDING ENTIRE BREAST EXTENDING TO THE AXILLARY REGION ULTRASOUND GUIDED FLUID ASPIRATION PERFORMED 2011 REVEALED ATYPICAL LYMPHOID PROLIFERATION CONSISTENT WITH CD30+ ALK-ALCL EXPLANT SURGERY PERFORMED TO REMOVE IMPLANT ADDL TREATMENT IS UNK AT THIS TIME|STYLE 468 SALINE FILLED BREAST IMPLANT|UNK STYLE 468|09/21/2011|||DA|N|R||0HP|FWM|1.0||nan||NI|||GOLETA|US|ALLERGAN||CA|||||True
1999354|14966427|D|1||INITIALLY PT REPORTED RIGHT SIDE LYMPHOMA DEFLATION INFECTION IRRITATIONINFLAMMATION WITH RIGHT BREAST IMPLANT FU WITH THE IMPLANTING SURGEONS OFFICE NOTED THE PT WAS SEEN IN THE EMERGENCY ROOM FOR WHAT WAS THOUGHT TO BE A RIGHT BREAST ABSCESS OR AN INFECTION THE PT WAS THEN SENT TO SEE THE IMPLANTING SURGEON WHO PERFORMED AN ANTIBIOTIC WASH AND HAD THE PT HAVE AN ULTRASOUND AS WELL OPERATIVE NOTES WERE REQUESTED AND STATE ON THE RIGHT SIDE ONCE INCISED WE ENCOUNTERED A LARGE VOLUME OF PURULENT FLUID THIS WAS SENT FOR CULTURE WE FOUND A COMPLETELY DEFLATED SALINE IMPLANT THE CAPSULE WAS ANGRY AND INFLAMED THE PATHOLOGY FINAL DIAGNOSIS ALCL CD30+ ALK- INCLUDING CD45+ THE PT WAS TO SEE AN ONCOLOGIST AT A LATER DATE ADDITIONAL INFO PROVIDED BY THE SURGEONS OFFICES NOTES THAT THE PT WAS SEEN BY THE ONCOLOGIST AND BREAST IMPLANT THAT WAS REMOVED WAS DISCARDED|STYLE 168 SALINE FILLED BREAST IMPLANT|168-800|02/14/2011||||N|R||0HP|FWM|1.0|08/01/1997|nan||2-505392|||GOLETA|US|ALLERGAN||CA|||||True
2564353|2651879|D|1||ANAPLASTIC LARGE CELL LYMPHOMA AND BREAST IMPLANTS FIVE B6 CASES PUBLISHED IN THE PLASTIC AND RECONSTRUCTIVE SURGERY B6 2012 B4 WITHIN THE ARTICLE THE AUTHOR DESCRIBES A B6 WOMAN WHO PRESENTED IN 2011 WITH A RIGHT BREAST LUMP HER HISTORY NOTES A WIDE LOCAL EXCISION OF THE RIGHT BREAST FOR DUCTAL CARCINOMA IN SITU FOLLOWED BY RADIOTHERAPY IN 1995 IN 1998 SHE HAD A MASTECTOMY FOR RECURRENT DISEASE AND RECONSTRUCTION WITH A PEDICLED LATISSIMUS DORSI FLAP IN 2006 SHE HAD A REVISION WITH A RIGHT BREAST AUGMENTATION SUBPECTORALIS AND LATISSIMUS DORSI FLAP AND LEFT BREAST AUGMENTATION FOR SYMMETRY SUBFASCIAL WITH A TEXTURED MCGHAN IMPLANTS SHE UNDERWENT AN OPEN BIOPSY IN WHICH TWO MASSES WERE FOUND ONE MEDIAL AND ONE LATERAL THE MEDIAL MASS WAS FOUND TO HAVE THE IMPLANT WHICH HAD RUPTURED IMMEDIATELY UNDER IT THE IMPLANT WAS REMOVED A TOTAL CAPSULECTOMY WAS PERFORMED AND THE IMPLANT REPLACED THE ASSUMPTION THE MASS WAS A SILICOMA HISTOPATHOLOGIC ANALYSIS REVEALED BOTH MASSES TO BE ALK- ALCL CD30+ AND THE REMAINDER OF THE CAPSULE WAS NEGATIVE THE REMAINDER OF HER WOUND FAILED TO HEAL AND THE RIGHT BREAST IMPLANT WAS REMOVED CT SCAN AND PET SCAN WERE NORMAL AS WAS THE BONE MARROW SHE BEGAN CHEMOTHERAPY WITH CYCLOPHOSPHAMIDE DOXORUBICIN VINCRISTINE AND PREDNISONE AND IS AWAITING RADIATION SHE CURRENTLY HAS NO RECURRENCE|UNK GEL BREAST IMPLANT|UNK GEL BREAST IMPLANT|05/01/2012|||DA|N|R||0HP|FTR|1.0||nan||NI|||GOLETA|US|ALLERGAN||CA|||||True
3405834|62723956|D|1||ADDITIONAL INFORMATION REPORTED FROM JOURNAL ARTICLE ANAPLASTIC LARGE CELL LYMPHOMA ASSOCIATED BREAST IMPLANT A CASE REPORT AND REVIEW OF THE LITERATURE DETORRES ET AL  REPORTS OF PRACTICAL ONCOLOGY AND RADIOTHERAPY 18 2013 DEVELOPED DURING THE FOLLOW UP AN AXILLARY LYMPH NODE THE EXCISIONAL BIOPSY OF THAT NODE SHOWED AN ALK NEGATIVE ALCL THE PET-TAC SHOWS A FOCAL INCREASED OF FDG UPTAKE AT LEFT AXILLAR REGION AND AT THE BREAST PROSTHETIC FLUID AREA WITH NO OTHER PATHOLOGICAL FINDINGS THE PATIENT RECEIVED 4 CYCLES OF CHOP CYCLOPHOSPHAMIDE DOXORUBICIN AND VINCRISTINE CHEMOTHERAPY THE PROSTHESES WAS REMOVED AND THEN THE PATIENT RECEIVED POSTOPERATIVE ADJUVANT RADIOTHERAPY ON THE CHEST WALL AND REGIONAL LYMPH NODES TO A TOTAL DOSE OF 36 GY NO PATHOLOGY OR FOLLOW-UP CONFIRMING CD30+ THEREFORE EVENT WILL REMAIN REPORTABLE AS LYMPHOMA|UNK MAMMARY IMPLANT|UNK MAMMARY IMPLANT|10/04/2013|||DA|N|R||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||NI|||GOLETA|US|UNKNOWN MANUFACTURER||CA|||||True
3405834|62724174|D|1||RECEIVED AN ARTICLE FROM PRODUCT WATCH ENTITLED ALCL ASSOCIATED BREAST IMPLANT A CASE REPORT AND REVIEW OF THE LITERATURE WRITTEN BY DETORRES ET AL WITHIN THE ARTICLE IT IS NOTED THE PATIENT HAD SEROMA AND LYMPHOMA THE MANUFACTURER OF THIS DEVICE IS UNKNOWN ADDITIONAL INFORMATION REPORTED FROM JOURNAL ARTICLE ANAPLASTIC LARGE CELL LYMPHOMA ASSOCIATED BREAST IMPLANT A CASE REPORT AND REVIEW OF THE LITERATURE DETORRES ET AL REPORTS OF PRACTICAL ONCOLOGY AND RADIOTHERAPY 18 2013 DEVELOPED DURING THE FOLLOW UP AN AXILLARY LYMPH NODE THE EXCISIONAL BIOPSY OF THAT NODE SHOWED AN ALK NEGATIVE ALCL THE PET-TAC SHOWS A FOCAL INCREASED OF FDG UPTAKE AT LEFT AXILLAR REGION AND AT THE BREAST PROSTHETIC FLUID AREA WITH NO OTHER PATHOLOGICAL FINDINGS THE PATIENT RECEIVED 4 CYCLES OF CHOP CYCLOPHOSPHAMIDE DOXORUBICIN AND VINCRISTINE CHEMOTHERAPY THE PROSTHESES WAS REMOVED AND THEN THE PATIENT RECEIVED POSTOPERATIVE ADJUVANT RADIOTHERAPY ON THE CHEST WALL AND REGIONAL LYMPH NODES TO A TOTAL DOSE OF 36 GY NO PATHOLOGY OR FOLLOW-UP CONFIRMING CD30+ THEREFORE EVENT WILL REMAIN REPORTABLE AS LYMPHOMA|UNK MAMMARY IMPLANT|UNK MAMMARY IMPLANT|10/04/2013|||DA|N|R||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||NI|||GOLETA|US|UNKNOWN MANUFACTURER||CA|||||True
3378227|3752540|D|1||HEALTHCARE PROFESSIONAL REPORTS A CASE OF ALCL AND SEROMA VIA ALLERGAN LEGAL DEPARTMENT B4 THE PATIENT HAS A HISTORY OF BREAST CANCER THAT WAS DIAGNOSED B62004 SHE HAD A TOTAL MASTECTOMY WITH LYMPHNODE DISSECTION ON B6 2004 ON B6 2006 THE PATIENT UNDERWENT RECONSTRUCTION SURGERY WITH LATISSISMUS DORSI FLAP USING ALLERGAN 110-480 TEXTURED DEVICES IN B6 2003 THE PATIENT HAD SIX ROUNDS OF CHEMO BUT DID NOT REQUIRE RADIATION ON B6 2013 THE PATIENT PRESENTED TO HER SURGEON WITH LEFT BREAST BREAST SWELLING ON A REFERRAL FROM HER PCP AN ULTRASOUND WAS CARRIED OUT B6 2013 EXPLANT SURGERY WITH COMPLETE CAPSULECTOMY ON B6 2013 WAS PERFORMED THE SEROMA WAS SENT TO THE LAB ALONG WITH THE IMPLANT AND THE CAPSULE DURING THE SURGERY THE PATIENT WAS ALSO NOTED TO HAVE NODULES UNDER THE LEFT BREAST IMPLANT THE HISTOLOGY REPORT NOTES ALCL ALK-MARKER CD30+|STYLE 110 SILICONE GEL FILLED BREAST IMPLANT|110-480|09/17/2013|||DA|N|R||0HP|FTR|1.0||nan||NI|||GOLETA|US|ALLERGAN||CA|||||True
3134127|61102727|N|1||MEDWATCH SUBMITTED TO THE FDA ON 07162015 ADVERSE EVENT OF ALCL WAS REPORTED PREVIOUSLY BUT AS THERE IS NO PATHOLOGY OR FOLLOW-UP CONFIRMING CD30+ OR ALK- THE EVENT WILL REMAIN REPORTABLE AS LYMPHOMA|STYLE 410 COHESIVE SILICONE GEL FILLED BREAST IMPLANT|UNK STYLE 410|05/24/2013|||DA|N|R||0HP|FTR|1.0||nan||NI|||ARKLOW, COUNTY WICKLOW|EI|ALLERGAN|||||||True
3031014|3257466|D|1||HEALTHCARE PROFESSIONAL REPORTS IN AN ARTICLE A CASE OF SEROMA AND ALCL THE LANCET 2012 380 1530 WITHIN THE ARTICLE THE AUTHOR REPORTS IN B4 2010 A PREVIOUSLY HEALTHY B6 WOMAN WITH TEXTURED SALINE BREAST IMPLANTS PLACED SUBPECTORALLY 8 YEARS AGO FOR AESTHETIC PURPOSES PRESENTED WITH 2-MONTH HISTORY OF A PAINLESS MASS UNDERNEATH HER LEFT ARM PHYSICAL EXAMINATION SHOWED A SYMMETRICAL BREASTS WITH NO OVERLYING SKIN OR NIPPLE CHANGES THERE WERE TWO LARGE MOBILE NODES PALPABLE IN THE LEFT AXILLA INITIAL BREAST MAMMOGRAPHY AND ULTRASONOGRAPHY CONFIRMED LEFT AXILLARY LYMPHADENOPATHY BUT DID NOT SHOW ANY PERI-IMPLANT FLUID COLLECTION BIOPSY OF THE LEFT AXILLARY MASS SHOWED FINDINGS CONSISTENT WITH CLASSIC HODGKINS LYMPHOMA NODULAR SCLEROSING TYPE IT LACKED TWO TYPICAL STAINS-CD15 AND PAX5 PET-CT SHOWED A 5-CM AREA OF PET-AVID LEFT AXILLARY LYMPHADENOPATHY HODGKINS LYMPHOMA STAGE IA WAS DIAGNOSED THE PT THEN HAD TWO CYCLES OF ADRIAMYCIN BLEOMYCIN VINBLASTINE AND DACARBAZINE ABVD AND 2000 GY OF FIELD RADIATION TO THE LEFT AXILLA HER INITIAL TREATMENT WAS COMPLETED IN B6 2011 FU CT SCAN IN B6 2011 SHOWED A DECREASE IN THE SIZE OF THE LEFT AXILLARY LYMPHADENOPATHY UNILATERAL FLUID COLLECTION HOWEVER WAS NOTED AROUND THE LEFT BREAST IMPLANT FIGURE THE FLUID INCREASED IN SIZE AND SHE PRESENTED 6 MONTHS ALTER WITH LEAKAGE OF SEROUS FLUID FROM HER LEFT BREAST CYTOLOGY OF THE PERI-IMPLANT FLUID SHOWED CD30+ LYMPHOMA CELLS OF INDETERMINATE LINEAGE DIFFERENT DIAGNOSIS INCLUDED RECURRENT HODGKINS LYMPHOMA OR IMPLANT-ASSOCIATED ANAPLASTIC LARGE-CELL LYMPHOMA REPEAT PET-CT SHOWED PET-AVID AREAS ON BILATERAL AXILLARY LYMPH NODES BOTH IMPLANTS WERE REMOVED WITH CAPSULECTOMIES IN B6 2011 SHE REPEAT PET-CT SHOWED PET-AVID AREAS IN BILATERAL AXILLARY LYMPH NODES BOTH IMPLANTS WERE REMOVED WITH CAPSULECTOMIES IN B6 2011 SHE WAS TREATED WITH FOUR CYCLES OF SALVAGE CHEMOTHERAPY WITH GEMCITABINE AND CISPLATIN FOR ASSUMED RECURRENT HODGKINS LYMPHOMA FU SONOGRAPHY OF THE LEFT BREAST 1 MONTH LATER SHOWED A HYPOECHOIC MASS BIOPSY OF THE MASS SHOWED SIMILAR CELLS FROM THE PERI-IMPLANT FLUID WHICH WERE CD30+ LYMPHOMA CELLS OF INDETERMINATE ORIGIN THE MASS WAS RESECTED IN B6 2012 AND PATHOLOGICAL TESTS SHOWED B6 SEROMA-ASSOCIATED LARGE-CELL LYMPHOMA ALK-NEGATIVE ALCL A RETROSPECTIVE REVIEW OF ALL SIDES SHOWED LARGE CELLS CHARACTERISTIC OF ALK-NEGATIVE ALCL SUBSTANTIAL OVERLAP IN MORPHOLOGY AND IMMUNOPHENOTYPE OF CELLS FROM THE INITIAL AXILLARY LYMPH NODE BIOPSY THE PERI-IMPLANT FLUID AND THE FINAL LEFT BREAST MASS BIOPSY SUGGESTED THE SAME MANIFESTATIONS OF THE ALCL THE PRESENTATION IS UNIQUE BECAUSE ALK-NEGATIVE ALCL PRESENTED WITH A PATHOLOGICAL AXILLARY LYMPH NODE INSTEAD OF THE TYPICAL PERI-IMPLANT SEROMA OUR PT COMPLETED BRENTUXIMAB THERAPY FOR TREATMENT OF ALK-NEGATIVE ALCL THE PT WAS LAST SEEN ON B6 2012 AND IS IN STABLE CONDITION|UNK SALINE IMPLANT|UNK SALINE IMPLANT|11/15/2012|||DA|N|R||0HP|FWM|1.0||nan||NI|||GOLETA|US|ALLERGAN||CA|||||True
3520860|3971929|D|1||PHYSICIAN REPORTED TUMORAL SYNDROME DURING THE SYSTEMATIC CHANGE OF IMPLANT SURGERY OCCURRED IN B6 ON B6 2013 THE SURGEON REMOVED SOME IRREGULARITIES OF THE CAPSULE AND IMPLANTED A NEW DEVICE DURING THE SUMMER AN INCREASE OF BREAST VOLUME WAS NOTED THE PATIENT WAS SEEN IN EMERGENCY ON B6 2013 AND HAD EMERGENCY SURGERY ON B6 2013 FOR SUSPICION OF SEPSIS OR BIG CELL LYMPHOMA CD30+ EXPLANTATION OF THE DEVICE AND TOTAL CAPSULECTOMY WAS PERFORMED IRREGULARITIES IN THE MEMBRANE AROUND THE DEVICE AND SEROMA WAS REPORTED MULTIPLE ATTEMPTS HAVE BEEN MADE REQUESTING FURTHER INFORMATION INCLUDING CYSTOLOGY REPORTS AND RETURN OF THE DEVICE|UNK MAMMARY IMPLANT|UNK MAMMARY IMPLANT|11/20/2013|||DA|N|R||0HP|FWM|1.0||nan||NI|||GOLETA|US|ALLERGAN||CA|||||True
2903656|3063201|D|1||ALCL CASE REPORT DIAGNOSIS ALK NEGATIVE ANAPLASTIC LARGE CELL LYMPHOMA CD30+ SP LEFT AXILLARY LN BIOPSY 52110 THE PT IS A B6 FEMALE WITH STAGE IV ALK NEGATIVE ANAPLASTIC LARGE-CELL LYMPHOMA THIS WAS DIAGNOSED ON B6 2010 SHE IS CURRENTLY UNDERGOING CHEMOTHERAPY AND IS FOLLOWED HERE IN ONCOLOGY SHE HAD BILATERAL BREAST AUGMENTATION WITH SILICONE IMPLANTS OVER 30 YEARS AGO SHE HAD A RUPTURE ON THE RIGHT SIDE AND HAD THE IMPLANTS REMOVED AND REPLACED IN 2005 BY A LOCAL PLASTIC SURGEON SHE STATES THEY ARE SUBPECTORAL THROUGH AN INFRAMAMMARY FOLD INCISION SHE BELIEVES THE RIGHT IMPLANT WAS 325 CC AND THE LEFT WAS 350 CC DURING ONE OF HER RECENT CT SCANS PERFORMED FOR LYMPHOMA STAGING THERE APPEARED TO BE EVIDENCE OF RUPTURE OF HER RIGHT BREAST IMPLANT I REMOVED BOTH IMPLANTS ON B6 2012 THEY WERE NOT REPLACED DUE TO THE POSSIBLE LINK BETWEEN BREAST IMPLANTS AND ALCL|INAMED||12/28/2012|||||||0HP|FTR|2.0||SILICONE BREAST IMPLANT||NONE|||IRVINE|US|ALLERGAN||CA|||STYLE 110|REF# 110-390|True
2903656|3063201|D|1||ALCL CASE REPORT DIAGNOSIS ALK NEGATIVE ANAPLASTIC LARGE CELL LYMPHOMA CD30+ SP LEFT AXILLARY LN BIOPSY 52110 THE PT IS A B6 FEMALE WITH STAGE IV ALK NEGATIVE ANAPLASTIC LARGE-CELL LYMPHOMA THIS WAS DIAGNOSED ON B6 2010 SHE IS CURRENTLY UNDERGOING CHEMOTHERAPY AND IS FOLLOWED HERE IN ONCOLOGY SHE HAD BILATERAL BREAST AUGMENTATION WITH SILICONE IMPLANTS OVER 30 YEARS AGO SHE HAD A RUPTURE ON THE RIGHT SIDE AND HAD THE IMPLANTS REMOVED AND REPLACED IN 2005 BY A LOCAL PLASTIC SURGEON SHE STATES THEY ARE SUBPECTORAL THROUGH AN INFRAMAMMARY FOLD INCISION SHE BELIEVES THE RIGHT IMPLANT WAS 325 CC AND THE LEFT WAS 350 CC DURING ONE OF HER RECENT CT SCANS PERFORMED FOR LYMPHOMA STAGING THERE APPEARED TO BE EVIDENCE OF RUPTURE OF HER RIGHT BREAST IMPLANT I REMOVED BOTH IMPLANTS ON B6 2012 THEY WERE NOT REPLACED DUE TO THE POSSIBLE LINK BETWEEN BREAST IMPLANTS AND ALCL|INAMED||12/28/2012||10/01/2012||R|||0HP|FTR|1.0||SILICONE BREAST IMPLANT||NONE|||IRVINE|US|ALLERGAN||CA|||STYLE 110|REF# 110-420|True
4012140|18368421|D|1||ON B6 2014 RECEIVED AN ARTICLE ENTITLED BREAST IMPLANT-ASSOCIATED ALCL REPORT OF 2 CASES AND REVIEW OF THE LITERATURE AESTHETIC SURGERY JOURNAL 06172014 WITHIN THE ARTICLE IT NOTES A CASE OF A B6 PT WHO PRESENTED WITH AN ACUTE ENLARGEMENT OF RIGHT BREAST SWELLING SIXTEEN YEARS EARLIER THE PT HAD A BILATERAL AUGMENTATION SURGERY 425CC TEXTURED ROUND IMPLANTS WERE PLACED SUBGLANDULARLY THE MFR OF THE IMPLANTS WAS NOT KNOWN THE PT DID NOT UNDERGO ANY ADDITIONAL BREAST SURGERY BEFORE PRESENTING TO THE OFFICE CLINICAL EXAM SHOWED SWELLING OF THE RIGHT BREAST BUT NO MASSES US SHOWED A FLUID COLLECTION AROUND THE RIGHT IMPLANT THAT WAS INTACT MRI CONFIRMED THE PRESENCE OF FLUID AND DID NOT REVEAL ANY MASSES US GUIDED ASPIRATION SHOWED CD30+ ALK-ALCL THE CELLS WERE ALSO POSITIVE FOR CD45 CD5 CD4 BUT FAILED TO EXPRESS CD34 CD20 CD68 OR CD10 THE PT UNDERWENT BILATERALLY CAPSULECTOMIES AND IMPLANT REMOVAL WITHOUT REPLACEMENT ON B6 2012 THERE WAS NO SILICONE FOUND IN THE CAPSULE THE PT WAS SENT TO ONCOLOGY THE PT DID NOT RECEIVE ANY ADDITIONAL TREATMENT AND HAS BEEN DISEASE FREE SINCE HER 15 MONTH FOLLOW-UP THE PT CONTINUES TO HAVE PAIN IN THE AFFECTED BREAST THIS REPRESENTS CASE 2|UNK SALINE IMPLANT|UNK SALINE IMPLANT|07/16/2014|||DA|N|R||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||NI|||GOLETA|US|UNKNOWN MANUFACTURER||CA||||NI|True
4012140|55598047|D|1||ON 25JUN2014 RECEIVED AN ARTICLE ENTITLED BREAST IMPLANT-ASSOCIATED ALCL REPORT OF 2 CASES AND REVIEW OF THE LITERATURE AESTHETIC SURGERY JOURNAL 17JUN2014  WITHIN THE ARTICLE IT NOTES A CASE OF A B6 PATIENT WHO PRESENTED WITH AN ACUTE ENLARGEMENT OF RIGHT BREAST SWELLING SIXTEEN YEARS EARLIER THE PATIENT HAD A BILATERAL AUGMENTATION SURGERY 425CC TEXTURED ROUND IMPLANTS WERE PLACED SUBGLANDULARLY THE MANUFACTURER OF THE IMPLANTS WAS NOT KNOWN THE PATIENT DID NOT UNDERGO ANY ADDITIONAL BREAST SURGERY BEFORE PRESENTING TO THE OFFICE CLINICAL EXAM SHOWED SWELLING OF THE RIGHT BREAST BUT NO MASSES US SHOWED A FLUID COLLECTION AROUND THE RIGHT IMPLANT THAT WAS INTACT MRI CONFIRMED THE PRESENCE OF FLUID AND DID NOT REVEAL ANY MASSES US GUIDED ASPIRATION SHOWED CD30+ ALK-ALCL THE CELLS WERE ALSO POSITIVE FOR CD45 CD5 CD4 BUT FAILED TO EXPRESS CD34 CD20 CD68 OR CD10 THE PATIENT UNDERWENT BILATERALLY CAPSULECTOMIES AND IMPLANT REMOVAL WITHOUT REPLACEMENT ON B6 2012 THERE WAS NO SILICONE FOUND IN THE CAPSULE THE PATIENT WAS SENT TO ONCOLOGY THE PATIENT DID NOT RECEIVE ANY ADDITIONAL TREATMENT AND HAS BEEN DISEASE FREE SINCE 15 MONTH FOLLOW UP THE PATIENT CONTINUES TO HAVE PAIN IN THE AFFECTED BREAST THIS REPRESENTS CASE 2|UNK SALINE IMPLANT|UNK SALINE IMPLANT|07/16/2014|||DA|N|R||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||NI|||GOLETA|US|UNKNOWN MANUFACTURER||CA||||NI|True
4385755|16883770|D|1||HEALTH PROFESSIONAL REPORTED PT DEVELOPED AXILLARY PERICAPSULAR AND SUPRACLAVICULAR MASSES DIAGNOSED AS CD30+ ALK-ALCL AND SYNCHRONOUS HODGKINS LYMPHOMA TREATED WITH BILATERAL IMPLANT REMOVAL CAPSULECTOMIES CHEMOTHERAPY WITH CHOP X 3 ROUNDS AND RADIATION TO THE AXILLA FOLLOW UP IMAGING WITH CT SCAN NO RECURRENCE OF DISEASE REMAINS HEALTHY ALCL AFFECTED BREAST REPORTED AS UNILATERAL -LEFT HEALTH PROFESSIONAL ADDITIONALLY REPORTED CAPSULAR CONTRACTURE BAKER GRADE III|UNK GEL BREAST IMPLANT|UNK GEL BREAST IMPLANT|12/24/2014|||DA|N|R||0HP|FTR|1.0||PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||NI|||LA AURORA DE HEREDIA|CS|UNKNOWN MANUFACTURER|||||||True
4385755|54780897|D|1||HEALTH PROFESSIONAL REPORTED PATIENT DEVELOPED AXILLARY PERICAPSULAR AND SUPRACLAVICULAR MASSES DIAGNOSED AS CD30+ ALK- ALCL AND SYNCHRONOUS HODGKINS LYMPHOMA TREATED WITH BILATERAL IMPLANT REMOVAL CAPSULECTOMIES CHEMOTHERAPY WITH CHOP X 3 ROUNDS AND RADIATION TO THE AXILLA FOLLOW UP IMAGING WITH CT SCAN NO RECURRENCE OF DISEASE REMAINS HEALTHY ALCL AFFECTED BREAST REPORTED AS UNILATERAL - LEFT HEALTH PROFESSIONAL ADDITIONALLY REPORTED CAPSULAR CONTRACTURE BAKER GRADE III|UNK GEL BREAST IMPLANT|UNK GEL BREAST IMPLANT|12/24/2014|||DA|N|R||0HP|FTR|1.0||PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||NI|||LA AURORA DE HEREDIA|CS|UNKNOWN MANUFACTURER|||||||True
4680690|5622102|D|1||MEDICAL STAFF REPORTED RIGHT SIDE DEVICE REMOVAL DUE TO ANATOMIC PATHOLOGICAL MACROBIOPSY OF A LUMP FROM THE UPPER RIGHT BREAST SHOWED PROLIFERATION OF LYMPHOMA WITH DIFFUSE LARGE B-CELL CD30+ ALK- THE MORPHOLOGICAL AND IMMUNOHISTOCHEMICAL CHARACTERISTICS ARE IN FAVOR OF A LAGC CD30+ ALK- EVENT WAS ADDITIONALLY TREATED WITH J1C1BENDAMUSTINE PALLIATIVE ADDITIONAL REPORT OF DEATH OF THE PT DUE TO THE EVOLUTION OF THE DISEASE|STYLE 410 COHESIVE SILICONE GEL FILLED BREAST IMPLANT|27-LF140-440|04/09/2015|||DA|N|R||0HP|FTR|1.0|03/20/2012|nan||1408999|||ARKLOW, COUNTY WICKLOW|EI|ALLERGAN|||||||True
4385750|20374001|D|1||HEALTH PROFESSIONAL REPORTED PT DEVELOPED RAPID DELAYED SEROMA DIAGNOSED AS CD30+ ALK- ALCL OF MALIGNANT EFFUSION TREATED WITH BILATERAL IMPLANT REMOVAL CAPSULECTOMIES CHEMOTHERAPY WITH CHOP FU IMAGING WITH CT SCAN NO RECURRENCE OF DISEASE ALCL AFFECTED BREAST REPORTED AS UNILATERAL - RIGHT STAGE IE|UNK SALINE IMPLANT|UNK SALINE IMPLANT|12/24/2014|||DA|N|R||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||NI|||LA AURORA DE HEREDIA|CS|UNKNOWN MANUFACTURER|||||||True
4385750|55048878|D|1||HEALTH PROFESSIONAL REPORTED PATIENT DEVELOPED RAPID DELAYED SEROMA DIAGNOSED AS CD30+ ALK- ALCL OF MALIGNANT EFFUSION TREATED WITH BILATERAL IMPLANT REMOVAL CAPSULECTOMIES CHEMOTHERAPY WITH CHOP FOLLOW UP IMAGING WITH CT SCAN NO RECURRENCE OF DISEASE ALCL AFFECTED BREAST REPORTED AS UNILATERAL - RIGHT STAGE IE|UNK SALINE IMPLANT|UNK SALINE IMPLANT|12/24/2014|||DA|N|R||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||NI|||LA AURORA DE HEREDIA|CS|UNKNOWN MANUFACTURER|||||||True
4385811|5262304|D|1||HEALTH PROFESSIONAL REPORTED PT RECEIVED BILATERAL MASTECTOMIES OF NOTE ON PTS PATHOLOGY CD30+ ALK-ALCL STAGE IE  WAS FOUND IN THE CONTRALATERAL RIGHT BREAST AT TIME OF MASTECTOMY|UNK GEL BREAST IMPLANT|UNK GEL BREAST IMPLANT|12/24/2014|||DA|N|R||0HP|FTR|1.0||PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||NI|||LA AURORA DE HEREDIA|CS|UNKNOWN MANUFACTURER|NE||NE||||True
4385811|55591407|D|1||HEALTH PROFESSIONAL REPORTED PATIENT RECEIVED BILATERAL MASTECTOMIES OF NOTE ON PATIENTS PATHOLOGY CD30+ ALK- ALCL STAGE IE WAS FOUND IN THE CONTRALATERAL RIGHT BREAST AT TIME OF MASTECTOMY|UNK GEL BREAST IMPLANT|UNK GEL BREAST IMPLANT|12/24/2014|||DA|N|R||0HP|FTR|1.0||PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||NI|||LA AURORA DE HEREDIA|CS|UNKNOWN MANUFACTURER|NE||NE||||True
4627437|5593685|D|1||HEALTH PROFESSIONAL REPORTED VIA VOLUNTARY MW5039349 ALCL CASE REPORT HISTORY OF BILATERAL BREAST AUGMENTATION PT HAS HX OF PAINFUL SWELLING OF LEFT BREAST AFTER A MAMMOGRAM SHE THEN HAD INDURATION AND ERYTHEMA OF INFERIOR PORTION OF LEFT BREAST PT UNDERWENT MRI AND SKIN BIOPSY OF THE INDURATED PORTION OF THE LEFT BREAST BY REPORT THE BIOPSY SHOWED INFLAMMATORY TISSUE BUT NO MALIGNANCY THE PT PRESENTED WITH INCREASED PAIN AND SWELLING OF THE LEFT BREAST THE LEFT BREAST WAS FIRM AND LARGER VOLUME THAN THE RIGHT BREAST PATIENT HAD AN AREA 5 X 8 CM OF ERYTHEMA ALONG THE INFERIOR ASPECT OF THE LEFT BREAST UPON REMOVAL PATIENT HAD DENSE FIBROSIS AND INDURATION OF THE SKIN AND UNDERLYING BREAST TISSUE ON THE LEFT FROZEN SECTION PATHOLOGY WAS CONSISTENT WITH PROBABLE INFLAMMATORY CARCINOMA ENTIRE CAPSULECTOMY PERFORMED BILATERALLY ON THE LEFT THE CAPSULE WAS THICK AND FIRM AND THE IMPLANT WAS COMPLETELY DEFLATED THE IMPLANT WAS SURROUNDED BY 250-300CC OF CREAM MONOGENOUS YELLOW FLUID THIS WAS SENT FOR CYTOLOGY PROCEDURE WAS BILATERAL CAPSULECTOMY WITH REMOVAL OF IMPLANTS AND CLOSURE OVER DRAINS THE IMPLANTS WERE MCGHAN TEXTURED SALINE IMPLANTS 270CC APPEARED TO BE SHAPED IMPLANTS NO OTHER IDENTIFYING MARKS ON IMPLANTS LYMPHOMA WILL BE CAPTURED UNTIL CONFIRMATION OF ALCL CD30+ AND ALK- IS RECEIVED|UNK SALINE IMPLANT|UNK SALINE IMPLANT|03/23/2015|||DA|N|R||0HP|FWM|1.0||nan||NI|||LA AURORA DE HEREDIA|CS|ALLERGAN|||||||True
5285827|34095038|D|1||ALLERGAN SALES REPRESENTATIVE REPORTED A REVISION CASE ON A PATIENT THAT HAD ALLERGAN IMPLANTSTHERE WAS FLUID AROUND THE DEVICE AND THE OFFICE SENT THE FLUID OFF TO BE CULTURED THE CULTURED FLUID CAME BACK POSITIVE FOR BREAST IMPLANT ASSOCIATED ALCL SIDE WAS UNSPECIFIED FOLLOW-UP WITH HEALTH PROFESSIONAL CONFIRMED THAT THE REASON FOR SURGERY WAS THE LEFT BREAST KEPT GETTING LARGER AND LARGER SWELLING PATHOLOGY NOTED OPAQUE ORANGE FLUID AND CONFIRMED PRESENCE OF CD30+ AND ALK- PATHOLOGY ALSO NOTED CLINICAL HISTORY LEFT BREAST IMPLANT MALPOSITION ALCL HAS BEEN CONFIRMED|STYLE 363 SALINE FILLED BREAST IMPLANT|363LF-560|12/10/2015|||DA|N|R||0HP|FWM|1.0|12/04/2010|PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||1375592|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN (COSTA RICA)|||||||True
5285827|33170547|D|1||ALLERGAN SALES REPRESENTATIVE REPORTED A REVISION CASE ON A PATIENT THAT HAD ALLERGAN IMPLANTSTHERE WAS FLUID AROUND THE DEVICE AND THE OFFICE SENT THE FLUID OFF TO BE CULTURED THE CULTURED FLUID CAME BACK POSITIVE FOR BREAST IMPLANT ASSOCIATED ALCL SIDE WAS UNSPECIFIED FOLLOW-UP WITH HEALTH PROFESSIONAL CONFIRMED THAT THE REASON FOR SURGERY WAS THE LEFT BREAST KEPT GETTING LARGER AND LARGER SWELLING PATHOLOGY NOTED OPAQUE ORANGE FLUID AND CONFIRMED PRESENCE OF CD30+ AND ALK- PATHOLOGY ALSO NOTED CLINICAL HISTORY LEFT BREAST IMPLANT MALPOSITION ALCL HAS BEEN CONFIRMED|STYLE 363 SALINE FILLED BREAST IMPLANT|363LF-560|12/10/2015|||DA|N|R||0HP|FWM|1.0|12/04/2010|PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||1375592|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN (COSTA RICA)|||||||True
5061707|25188102|D|1||HEALTH PROFESSIONAL REPORTED HISTORY L BREAST SIZE INCREASE RO SEROMA - ATYPICAL LEUKOCYTES CD30+ ALK- TREATMENT REPORTED AS TOTAL CAPSULECTOMY  EXPLANTATION FOLLOW UP DIAGNOSTIC TESTS RECEIVED CONFIRMED PRESENCE OF SEROMA AND ALCL BREAST ULTRASOUND STATES 375ML OF MINIMALLY TURBID STRAW COLOURED FLUID WAS ASPIRATED CYTOPATHOLOGY OF THIS FLUID REPORTS SPECIMEN RECEIVED L BREAST 20 ML OF CLEAR YELLOW FLUID CONCLUSION RARE ATYPICAL LARGE CD30+ CELLS PRESENT HISTOPATHOLOGY REPORT STATES  MICROSCOPIC DESCRIPTION THE ATYPICAL CELLS ARE STRONGLY CD30 MEMBRANE EXPRESSING ALK-1 ARE NEGATIVE THE DIAGNOSES STATES BREAST IMPLANT-ASSOCIATED LARGE CELL LYMPHOMA|STYLE 410 COHESIVE SILICONE GEL FILLED BREAST IMPLANT|27-MX125-370|09/08/2015||||N|R||0HP|FTR|1.0||PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||1331894|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN (COSTA RICA)|||||||True
4922479|6435381|D|1||HEALTH PROFESSIONAL REPORTED RIGHT SIDE DEVICE REMOVED DUE TO A SEROMA THAT SUDDENLY APPEARED WITH SWELLING OF MAMMARY FOR SEVERAL WEEKS DURING REMOVAL OF RIGHT SIDE IMPLANT A DOUBLE CAPSULE WAS FOUND PATHOLOGICAL TESTING OF THE SEROMA AND CAPSULE REVEALED PATHOLOGICAL MARKERS CD30+ AND ALK- AND FOCAL INFLAMMATORY CHRONIC REARRANGEMENTS THIS CONFIRMS DIAGNOSIS OF RIGHT SIDE ANAPLASTIC LARGE CELL LYMPHOMA ALCL|STYLE 410 COHESIVE SILICONE GEL FILLED BREAST IMPLANT|27-LF120-270|07/16/2015|||DA|N|R||0HP|FTR|1.0|08/25/2010|PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE, GEL-FILLED||1126779|||ARKLOW, COUNTY WICKLOW|EI|ALLERGAN|||||||True
5286834|33227134|D|1||HEALTH PROFESSIONAL REPORTED A PERIPROSTHETIC OEDEMA LEADING TO A PARTIAL CAPSULECTOMY ON THE CAPSULECTOMY LEFT SIDE PATIENT WAS DIAGNOSED WITH ALCL ANAPLASTIC LARGE CELL LYMPHOMA CD30+ ALK-|UNK GEL BREAST IMPLANT|UNK GEL BREAST IMPLANT|12/10/2015||||N|R||0HP|FTR|1.0||PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||NI|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN (COSTA RICA)|||||||True
4957654|55248981|D|1||ADDITIONAL INFORMATION PROVIDED BY HEALTHCARE PROFESSIONAL NOTES DIAGNOSTIC INFORMATION REPORTED CD30+ AND ALK- PATHOLOGICAL MARKERS TO CONFIRM ALCL HAVE BEEN RECEIVED PATIENT HAS SINCE RECEIVED B4 ROUNDS OF CHOEP TREATMENT B6 2015-B6 2016 B4 ROUNDS OF GDP TREATMENT B6 2016-B6 2016 AND B4 ROUNDS OF BRENTUXIMAB STARTING B6 2016 UNTIL PRESENT A STEM CELL TRANSPLANT IS PLANNED FOR B6 2016|STYLE 115 SILICONE GEL FILLED BREAST IMPLANT|115-290|07/30/2015||08/11/2015|DA|R|Y||0HP|FTR|1.0|06/14/2013|PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||1627441|||LA AURORA DE HEREDIA|CS|ALLERGAN|||||||True
5138318|27896968|D|1||ALLERGAN REPRESENTATIVE REPORTED A CASE OF ALCL RECEIVED FROM A PHYSICIAN IN WHICH THE PATIENT PRESENTED WITH SEROMA DRAINED SEROMA AND PROCEEDED TO SURGERY DID COMPLETE CAPSULECTOMY AND SEND CAPSULE TO PATHOLOGY PATHOLOGY CONFERRED CD30+ SIDE WAS UNSPECIFIED FOLLOW-UP WITH HEALTH PROFESSIONAL FOUND EXPANDING RIGHT BREAST CATEGORIZED AS SIGNIFICANT SEROMA THERE WAS CAPSULAR CONTRACTURE BUT THE BAKER GRADE WAS DIFFICULT TO DETERMINE DUE TO TENSION CAUSED BY SEROMA DEVICE WAS REMOVED AND INTRAOPERATIVELY NOTED MATERIAL INTRACAPSULE THAT APPEARED OLD HEMATOMA PATIENT HAS NOT YET HAD CHEMOTHERAPY OR RADIOTHERAPY IMMUNOHISTOCHEMISTRY ON THE MALIGNANT APPEARING TUMOR CELLS REVEALS THAT CELLS ARE NEGATIVE FOR CK7 AE1AE3 CD68 CK19 CK20 ER CD20 AND EMA TUMOR CELLS ARE POSITIVE FOR CD3 CD30 AND CD45 IMMUNOHISTOCHEMISTRY SUPPORTS DIAGNOSIS OF ANAPLASTIC LARGE CELL LYMPHOMA T CELL LYMPHOMA ALK- MARKER NOT CONFIRMED THIS EVENT WILL BE CAPTURED AS LYMPHOMA|STYLE 410 COHESIVE SILICONE GEL FILLED BREAST IMPLANT|27-MX155-685|10/08/2015||||N|R||0HP|FTR|1.0|11/28/2010|PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||1172190|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN (COSTA RICA)|||||||True
4672656|5689022|D|1||HEALTH PROFESSIONAL REPORTED LEFT SIDE DEVICE REMOVED DUE TO PTS REPORT OF SWOLLEN AND TIGHT FEELING HEALTH PROFESSIONAL NOTED A YELLOW CLEAR FLUID WAS DRAINED AND PATHOLOGY SHOWED CYTOLOGIC FEATURES CONSISTENT WITH ATYPICAL CELLS UPON REMOVAL DEVICE WAS NOTED TO BE UPSIDE DOWN AND THE LEFT BREAST CAPSULE HAD MALIGNANT CELLS THAT WERE FOCALLY INFILTRATING THE CAPSULAR SURFACE WITH ASSOCIATED NECROSIS PATHOLOGY RESULTS CONFIRM ANAPLASTIC LARGE CELL LYMPHOMA STRONG POSITIVE FOR CD30+|STYLE 163 SALINE FILLED BREAST IMPLANT|163-530|04/08/2015|||DA|N|R||0HP|FWM|1.0||nan||NI|||LA AURORA DE HEREDIA|CS|ALLERGAN|||||||True
4688919|5687161|D|1||REPORT OF AGGRESSIVE PRESENTATION OF BREAST IMPLANT ASSOCIATED ALK-1 NEGATIVE ALCL WITH BILATERAL AXILLARY LYMPH NODE INVOLVEMENT IN AN ARTICLE BY DR GOVIND BHAGAT REPRINTED IN INFORMA HEALTHCARE 2009 JOURNAL STATES FOLLOWING RECONSTRUCTION THE PT DEVELOPED RIGHT AXILLARY LYMPHADENOPATHY  RIGHT AXILLARY LN BIOPSY SHOWED A LARGE CELL NEOPLASM INFILTRATING AND EXPANDING THE SINUSES AN EXHAUSTIVE STAINING PANEL LED TO THE DIAGNOSIS OF AN ALK-1 NEGATIVE ALCL THE GROSSLY INTACT IMPLANT WAS REMOVED WITH CAPSULECTOMY RESULTS SHOW CD30+|UNK GEL BREAST IMPLANT|UNK GEL BREAST IMPLANT|04/13/2015|||DA|N|R||0HP|FTR|1.0||nan||NI|||LA AURORA DE HEREDIA|CS|ALLERGAN|||||||True
6145512|61450146|D|1||PHYSICIAN REPORTED CLOUDY YELLOW FLUID FROM BREAST PROSTHESIS AND DIAGNOSIS OF ANAPLASTIC LARGE CELL LYMPHOMA CYTOLOGICAL MARKERS CD30+ AND ALK- HAVE NOT BEEN CONFIRMED AS SUCH THIS EVENT WILL BE CAPTURED AS LYMPHOMA DEVICE WAS EXPLANTED THIS MEDWATCH IS FOR THE RIGHT SIDE DEVICE SEE MANUFACTURER REPORT  9617229-2016-00173 FOR LEFT SIDE REPORT|STYLE 168 SALINE FILLED BREAST IMPLANT|N-27-168211|12/05/2016||12/16/2016|DA|R|Y||0HP|FWM|1.0|09/03/2015|PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||2013309|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN (COSTA RICA)|||||||True
6145512|63919661|D|1||RECEIVED ADDITIONAL INFORMATION FROM PHYSICIAN REPORTING IN IMMUNOHISTOCHEMISTRY THESE TUMOR CELLS WHICH ARE STRICTLY LIMITED IN THE FIBRIN COATING ARE CD30+ AND ALK- THIS EVENT HAS BEEN CONFIRMED AS ALCL DIAGNOSIS OF ALCL OCCURRED ON B6 2016 PHYSICIAN ADDITIONALLY REPORTED INFLAMMATORY DERMAL CONNECTIVE TISSUE IN THE RIGHT SIDE RIGHT SIDE PAIN AND CAPSULAR CONTRACTURE BAKER GRADE II THIS MEDWATCH IS FOR THE RIGHT SIDE DEVICE SEE MANUFACTURER REPORT  9617229-2016-00173 FOR LEFT SIDE REPORT|STYLE 168 SALINE FILLED BREAST IMPLANT|N-27-168211|12/05/2016||12/16/2016|DA|R|Y||0HP|FWM|1.0|09/03/2015|PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||2013309|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN (COSTA RICA)|||||||True
6106201|65086177|D|1||PHYSICIAN REPORTS PATIENT WITH SWELLING IN LEFT BREAST LEFT SIDE SEROMA FLUID AND CD30+ LYMPHOMA TREATED AS BIA-ALCL TOTAL CAPSULECTOMY AND EXPLANT REPORTED AT THIS TIME ALCL HAS NOT BEEN CONFIRMED BY THE PATHOLOGICAL MARKER ALK- UNTIL ALLERGAN RECEIVES CONFIRMATION OF THE MARKERS THIS WILL BE TERM CODED AS LYMPHOMA|STYLE 410 COHESIVE SILICONE GEL FILLED BREAST IMPLANT|27-MX120-325|11/16/2016||12/14/2016|DA|R|Y||0HP|FTR|1.0|07/15/2008|PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||225212|KILBRIDE INDUSTRIAL ESTATE||ARKLOW, COUNTY WICKLOW||ALLERGAN (ARKLOW)|||||||True
6106201|60020511|D|1||PHYSICIAN REPORTS PATIENT WITH SWELLING IN LEFT BREAST LEFT SIDE SEROMA FLUID AND CD30+ LYMPHOMA TREATED AS BIA-ALCL TOTAL CAPSULECTOMY AND EXPLANT REPORTED AT THIS TIME ALCL HAS NOT BEEN CONFIRMED BY THE PATHOLOGICAL MARKER ALK- UNTIL ALLERGAN RECEIVES CONFIRMATION OF THE MARKERS THIS WILL BE TERM CODED AS LYMPHOMA|STYLE 410 COHESIVE SILICONE GEL FILLED BREAST IMPLANT|27-MX120-325|11/16/2016||12/14/2016|DA|R|Y||0HP|FTR|1.0|07/15/2008|PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||225212|KILBRIDE INDUSTRIAL ESTATE||ARKLOW, COUNTY WICKLOW||ALLERGAN (ARKLOW)|||||||True
5708570|46882994|D|1||HEALTH PROFESSIONAL REPORTED ALCL ASSOCIATED WITH SILICONE BREAST IMPLANT SIDE UNSPECIFIED FURTHER FOLLOW-UP REPORTED AS PATIENT DEVELOPED A MASS AND A SEROMA ON THE LEFT SIDE AN INITIAL BIOPSY WAS TAKEN OF THE MASS AND IT WAS DIAGNOSED AS FAT NECROSIS THE MASS AND THE SEROMA WERE CONFIRMED TO BE SEPARATE EVENTS THE DEVICE HAS NOT YET BEEN REMOVED AS THEY ARE PROCEEDING WITH CHEMOTHERAPY CURRENTLY THE PATIENT WILL HAVE IMPLANT REMOVAL AND CAPSULECTOMY PENDING THE SUCCESS OF CHEMOTHERAPY HEALTH PROFESSIONAL CONFIRMED VERBALLY THAT PATHOLOGY REPORTS STATED MARKERS WERE CD30+  ATYPICAL LYMPHOID INFILTRATE AND ALK-1|STYLE 20 SILICONE GEL FILLED BREAST IMPLANT|20-400|06/09/2016||||N|R||0HP|FTR|1.0||PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||NI|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN (COSTA RICA)|||||||True
6153182|61700301|D|1||JOURNAL ARTICLE Â¿AXILLARY LYMPHADENOPATHY AN OUTSTANDING PRESENTATION FOR BREAST IMPLANT-ASSOCIATED ALK-NEGATIVE ANAPLASTIC LARGE CELL LYMPHOMAÂ¿ REPORTS Â¿WE REPORT THE CASE OF A PATIENT PRESENTING WITH AN AXILLARY LYMPHADENOPATHY 8 YEARS AFTER BREAST PROSTHESES IMPLANTATION CLINICAL EXAMINATION ULTRASOUND AND MAGNETIC RESONANCE IMAGING DETECTED NO MAMMARY LESIONS THE LYMPH NODE SHOWED INTRASINUSOIDAL INFILTRATION BY LARGE PLEOMORPHIC CELLS EXPRESSING CD30 AND LACKING ALK-IMMUNOREACTIVITY TUMOR STAGING WAS NEGATIVE CELLS WITH IDENTICAL FEATURES WERE FOUND IN THE IPSILATERAL PERIPROSTHETIC CAPSULE THE PATIENT WAS TREATED WITH CHOP AND RADIOTHERAPY AND PATIENT IS ALIVE WITHOUT EVIDENCE OF DISEASE AFTER A 30-MONTH FOLLOW-UPÂ¿ FINE-NEEDLE ASPIRATION CYTOLOGY WAS TAKEN OF THE AXILLARY LYMPH NODE AND CD30+  ALK- WAS CONFIRMED DEVICE REMOVAL AND CAPSULECTOMY WAS PERFORMED MANUFACTURER OF THE DEVICE IS UNKNOWN|UNK GEL BREAST IMPLANT|UNK GEL BREAST IMPLANT|12/07/2016||||*|*||0HP|FTR|1.0||PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||NI|||||UNKNOWN MANUFACTURER|||||||True
5940718|69962843|D|1||HEALTHCARE PROFESSIONAL ADDITIONALLY REPORTED LEFT SIDE MASS AND INFLAMMATION PATHOLOGICAL MARKERS CD30+ AND ALK- HAVE BEEN RECEIVED THEREFORE LYMPHOMA ALCL HAS BEEN CONFIRMED|UNK MAMMARY IMPLANT|UNK MAMMARY IMPLANT|09/09/2016|||DA|N|R||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||NI|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN (COSTA RICA)|||||||True
6153188|61710212|D|1||LITERATURE ARTICLE Â¿BACTERIAL BIOFILM INFECTION DETECTED IN BREAST IMPLANT-ASSOCIATED ANAPLASTIC LARGE-CELL LYMPHOMAÂ¿ REPORTS Â¿TWENTY-SIX BREAST IMPLANTÂ¿ASSOCIATED ALCL SAMPLES WERE GATHERED FROM FOUR CENTERS FOR THIS INTERNATIONAL COLLABORATIVE STUDY FROM A TOTAL OF 22 PATIENTS TABLE 1Â¿ ARTICLE GOES ON TO STATE Â¿BOTH THE BREAST IMPLANTÂ¿ASSOCIATED ALCL AND NONTUMOR CAPSULE SAMPLES YIELDED HIGH MEAN NUMBERS OF BACTERIA BREAST IMPLANTÂ¿ASSOCIATED ALCL 47 Ã 106 CELLSMG OF TISSUE CAPSULE 49 Ã 106 CELLSMG OF TISSUE ANALYSIS OF THE MICROBIOME IN BREAST IMPLANTÂ¿ASSOCIATED ALCL SPECIMENS SHOWED SIGNIFICANT DIFFERENCES WITH SPECIES IDENTIFIED IN NONTUMOR CAPSULE SPECIMENS THERE WAS A SIGNIFICANTLY GREATER PROPORTION OF RALSTONIA SPP PRESENT IN ALCL SPECIMENS COMPARED WITH NONTUMOR CAPSULE SPECIMENS P  005 IN CONTRAST SIGNIFICANTLY MORE STAPHYLOCOCCUS SPP WERE FOUND ASSOCIATED WITH NONTUMOR CAPSULE SPECIMENS COMPARED WITH BREAST IMPLANTÂ¿ASSOCIATED ALCL SPECIMENS P  0001 BACTERIAL BIOFILM WAS VISUALIZED BOTH ON SCANNING ELECTRON MICROSCOPY AND FLUORESCENT IN SITU HYBRIDIZATIONÂ¿ CYTOLOGICAL MARKERS ALK- AND CD30+ HAVE BEEN REPORTED ACCORDING TO TABLE 1 Â¿CLINICAL SUMMARY OF BREAST IMPLANTÂ¿ASSOCIATED ALCL PATIENTSÂ¿ THERE WERE 3 CASES OF ALCL WHERE THE PRESENTATION IS Â¿NOT KNOWNÂ¿ THERE IS CURRENTLY NO WAY TO DETERMINE WHICH CASES HAD WHICH DEVICE TYPE OR TESTED NEGATIVE FOR BACTERIAL INFECTION THIS REPORT WILL CAPTURE 3 CASES OF ALCL WHERE THE PRESENTATION IS Â¿NOT KNOWNÂ¿|UNK MAMMARY IMPLANT|UNK MAMMARY IMPLANT|12/07/2016||||*|*||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||NI|||||UNKNOWN MANUFACTURER|||||||True
5904549|59237866|D|1||ADDITIONAL INFORMATION PATHOLOGY REPORTS SPECIFIES THAT THE FIBRINOID MATERIAL NEXT TO THE PROSTHESIS TESTED CD30+ AND ALK- THIS IS NOW A CONFIRMED CASE OF ALCL AND HAS BEEN CAPTURED AS LYMPHOMA-ALCL|CUI TEXTURED SILICONE GEL FILLED BREAST IMPLANT|MHP-460|08/25/2016||09/29/2016|DA|R|Y||0HP|FTR|1.0|05/15/2009|PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||303203|KILBRIDE INDUSTRIAL ESTATE|ZONA FRANCA|ARKLOW, COUNTY WICKLOW||ALLERGAN (ARKLOW)|||||||True
5991152|59996591|D|1||GOVERNING BODY ADDITIONALLY REPORTED RIGHT SIDE CAPSULAR PAIN AT RIGHT SIDE LYMPH NODE TUMOR SYNDROME PRURITUS SINE MATERIAL AXILLARY GANGLIONS AND ANAPLASTIC LARGE CELL LYMPHOMA CD30+ ALK -|STYLE 410 COHESIVE SILICONE GEL FILLED BREAST IMPLANT|N-27-MF135-420|09/30/2016||09/29/2016|DA|R|Y||0HP|FTR|1.0||PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||2334015|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN (COSTA RICA)|||||||True
6191866|62906213|D|1||HEALTHCARE PROFESSIONAL REPORTED BREAST IMPLANTS REMOVED TODAY DUE TO ALCL SIDE WAS NOT SPECIFIED THIS MEDWATCH REPRESENTS THE LEFT SIDE SEE MFR  9617229-2016-00248 FOR THE RIGHT SIDE AS PATHOLOGICAL MARKERS CONFIRMING ALK- AND CD30+ HAVE NOT BEEN RECEIVED THE EVENT OF Â¿DUE TO ALCLÂ¿ WILL BE REPORTED AS LYMPHOMA|STYLE 410 COHESIVE SILICONE GEL FILLED BREAST IMPLANT|N-27-LF145-490|12/20/2016||01/06/2017|DA|R|Y||0HP|FTR|1.0|10/11/2015|PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||2029824|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN (COSTA RICA)|||||||True
6191866|67358311|D|1||HEALTHCARE PROFESSIONAL REPORTED BREAST IMPLANTS REMOVED TODAY DUE TO ALCL SIDE WAS NOT SPECIFIED AS PATHOLOGICAL MARKERS CONFIRMING ALK- AND CD30+ HAVE NOT BEEN RECEIVED THE EVENT OF Â¿DUE TO ALCLÂ¿ WILL BE REPORTED AS LYMPHOMA ADDITIONAL INFORMATION RECEIVED FROM THE HEALTHCARE PROFESSIONAL STATED PATIENT Â¿PRESENTED WITH LATE ONSET SEROMA LEFT BREAST ASPIRATE CONFIRMED ATYPICAL CELLS STRONGLY POSITIVE FOR CD30 T CELLS ALK NEGATIVE EMA POSITIVE THE DEVICE WAS EXPLANTED AND A CAPSULECTOMY WAS PERFORMED THE LEFT SIDE SHOWED SMALL CLUSTERS OF ATYPICAL CELLS IN SURFACE MATERIAL ON CAPSULE POSITIVE FOR CD30 EMA CD4 BUT NO INVASION EFFUSION ASSOCIATED ALCLÂ¿ PATHOLOGICAL MARKERS HAVE BEEN RECEIVED CONFIRMING ALCL PATIENT ADDITIONALLY EXPERIENCED CAPSULAR CONTRACTURE BAKER GRADE III THIS MEDWATCH REPRESENTS THE LEFT SIDE|STYLE 410 COHESIVE SILICONE GEL FILLED BREAST IMPLANT|N-27-LF145-490|12/20/2016||01/06/2017|DA|R|Y||0HP|FTR|1.0|10/11/2015|PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||2029824|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN (COSTA RICA)|||||||True
6191882|62905365|D|1||HEALTHCARE PROFESSIONAL REPORTED BREAST IMPLANTS REMOVED TODAY DUE TO ALCL SIDE WAS NOT SPECIFIED THIS MEDWATCH REPRESENTS THE RIGHT SIDE SEE MFR  9617229-2016-00212 FOR THE LEFT SIDE AS PATHOLOGICAL MARKERS CONFIRMING ALK- AND CD30+ HAVE NOT BEEN RECEIVED THE EVENT OF Â¿DUE TO ALCLÂ¿ WILL BE REPORTED AS LYMPHOMA|STYLE 410 COHESIVE SILICONE GEL FILLED BREAST IMPLANT|27-LF145-490|12/20/2016|||DA|N|R||0HP|FTR|1.0||PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||NI|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN (COSTA RICA)|||||||True
6145514|61451048|D|1||PHYSICIAN REPORTED CLOUDY YELLOW FLUID FROM BREAST PROSTHESIS AND DIAGNOSIS OF ANAPLASTIC LARGE CELL LYMPHOMA CYTOLOGICAL MARKERS CD30+ AND ALK- HAVE NOT BEEN CONFIRMED AS SUCH THIS EVENT WILL BE CAPTURED AS LYMPHOMA DEVICE WAS EXPLANTED THIS MEDWATCH IS FOR THE LEFT SIDE DEVICE SEE MANUFACTURER REPORT B4 FOR RIGHT SIDE REPORT|STYLE 168 SALINE FILLED BREAST IMPLANT|N-27-168211|12/05/2016||12/16/2016|DA|R|Y||0HP|FWM|1.0|09/09/2015|PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||2013310|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN (COSTA RICA)|||||||True
6145514|64146443|D|1||PHYSICIAN REPORTED FIRST LEFT BREAST SEROMA OCCURRING ON B6 2014 AND A SECOND LEFT BREAST SEROMA OCCURRING ON B6 2016 RECEIVED ADDITIONAL INFORMATION FROM PHYSICIAN REPORTING ANALYSIS OF SLIGHTLY CLOUDY ORANGE FLUID RESULTED IN LARGE CELLS TESTING CD30+ AND ALK- PHYSICIAN ADDITIONALLY REPORTED IN IMMUNOHISTOCHEMISTRY THESE TUMOR CELLS WHICH ARE STRICTLY LIMITED IN THE FIBRIN COATING ARE CD30+ AND ALK- THIS EVENT HAS BEEN CONFIRMED AS ALCL DIAGNOSIS OF ALCL OCCURRED ON B6 2016 PHYSICIAN ADDITIONALLY REPORTED INFLAMMATORY COMPONENTS IN THE LEFT SIDE LEFT SIDE PAIN AND CAPSULAR CONTRACTURE BAKER GRADE II THIS MEDWATCH IS FOR THE LEFT SIDE DEVICE SEE MANUFACTURER REPORT  9617229-2016-00174 FOR RIGHT SIDE REPORT|STYLE 168 SALINE FILLED BREAST IMPLANT|N-27-168211|12/05/2016||12/16/2016|DA|R|Y||0HP|FWM|1.0|09/09/2015|PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||2013310|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN (COSTA RICA)|||||||True
6180550|62543962|D|1||PHYSICIAN REPORTED A PATIENT EXPERIENCED COMPLICATIONS 11 YEARS AFTER BREAST IMPLANTATION PHYSICIAN EXPLANTED DEVICE AND SENT A SAMPLE FOR TESTING SAMPLE TESTED POSITIVE FOR ALCL SIDE IS UNKNOWN AT THIS TIME ALCL HAS NOT BEEN CONFIRMED BY THE PATHOLOGICAL MARKERS CD30+ AND ALK- UNTIL ALLERGAN RECEIVES CONFIRMATION OF THE MARKERS THIS WILL BE REPRESENTED BY TERM CODE LYMPHOMA|UNK GEL BREAST IMPLANT|UNK GEL BREAST IMPLANT|12/16/2016||||*|*||0HP|FTR|1.0||PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||NI|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN (COSTA RICA)|||||||True
5788476|53800763|D|1||HEALTH PROFESSIONAL REPORTED BREAST VOLUME INCREASE 5 YEARS AFTER REPLACEMENT AS PART OF MAMMARY MASTECTOMY PERIPROSTHETIC EXTRAVASATION REMOVAL OF PROSTHESIS + TOTAL CAPSULECTOMY ANAPATH RESULTS ALCL CONFIRMED SIDE WAS NOT SPECIFIED FURTHER INFORMATION RECEIVED REPORTS INCREASE OF THE VOLUME OF THE LEFT BREAST WITH EFFUSION DISCOVERED VIA MRI WITHOUT PROSTHETIC LEAK WITHOUT REDNESS NO PAIN OR FEVER IMPLANT REMOVAL AND TOTAL CAPSULECTOMY THE IMPLANT WAS FOUND INTACT A SAMPLE IS TAKEN AND DIAGNOSIS OF ALCL AIM CD30+ ALK- WILL BE DONE BY HISTOLOGICAL ANALYSIS CONFIRMED BY THE NETWORK LYMPHOPATH PATHOLOGICAL MARKERS TO CONFIRM ALCL HAVE NOT BEEN RECEIVED PATHOLOGICAL MARKERS TO CONFIRM ALCL HAVE NOT BEEN RECEIVED|STYLE 410 COHESIVE SILICONE GEL FILLED BREAST IMPLANT|N-27-MX125-370|07/12/2016|||DA|N|R||0HP|FTR|1.0|07/25/2016|PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||2149083|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN (COSTA RICA)|||||||True
5788476|51513752|D|1||FURTHER INFORMATION RECEIVED REPORTS INCREASE OF THE VOLUME OF THE LEFT BREAST WITH EFFUSION DISCOVERED VIA MRI WITHOUT PROSTHETIC LEAK WITHOUT REDNESS NO PAIN OR FEVER IMPLANT REMOVAL AND TOTAL CAPSULECTOMIE THE IMPLANT WAS FOUND INTACT A SAMPLE IS TAKEN AND DIAGNOSIS OF ALCL AIM CD30+ ALK- WILL BE DONE BY HISTOLOGICAL ANALYSIS CONFIRMED BY THE NETWORK LYMPHOPATH PATHOLOGICAL MARKERS TO CONFIRM ALCL HAVE NOT BEEN RECEIVED|STYLE 410 COHESIVE SILICONE GEL FILLED BREAST IMPLANT|N-27-MX125-370|07/12/2016|||DA|N|R||0HP|FTR|1.0|07/25/2016|PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||2149083|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN (COSTA RICA)|||||||True
6153200|61697779|D|1||LITERATURE ARTICLE Â¿COMPLETE SURGICAL EXCISION IS ESSENTIAL FOR THE MANAGEMENT OF PATIENTS WITH BREAST IMPLANTÂ¿ASSOCIATED ANAPLASTIC LARGE-CELL LYMPHOMAÂ¿ REPORTS Â¿87 PATIENTS WITH BI-ALCL INCLUDING 50 PREVIOUSLY REPORTED IN THE LITERATURE AND 37 UNREPORTEDÂ¿ ARTICLE CONTINUES TO STATE Â¿BREAST IMPLANTÂ¿ASSOCIATED ANAPLASTIC LARGE-CELL LYMPHOMA BI-ALCL IS A RARE TYPE OF T-CELL LYMPHOMA THAT ARISES AROUND BREAST IMPLANTS THE OPTIMAL MANAGEMENT OF THIS DISEASE HAS NOT BEEN ESTABLISHED THE GOAL OF THIS STUDY IS TO EVALUATE THE EFFICACY OF DIFFERENT THERAPIES USED IN PATIENTS WITH BI-ALCL TO DETERMINE AN OPTIMAL TREATMENT APPROACHÂ¿ Â¿THE MEDIAN AND MEAN FOLLOW-UP TIMESWERE 45 AND 30 MONTHS RESPECTIVELY RANGE 3 TO 217 MONTHS THE MEDIAN OVERALL SURVIVAL OS TIME AFTER DIAGNOSIS OF BI-ALCL WAS 13 YEARS AND THE OS RATE WAS 93AND 89AT 3 AND 5 YEARS RESPECTIVELY PATIENTS WITH LYMPHOMA CONFINED BY THE FIBROUS CAPSULE SURROUNDING THE IMPLANT HAD BETTER EVENT-FREE SURVIVAL EFS AND OS THAN DID PATIENTS WITH LYMPHOMA THAT HAD SPREAD BEYOND THE CAPSULE P = 03 PATIENTS WHO UNDERWENT A COMPLETE SURGICAL EXCISION THAT CONSISTED OF TOTAL CAPSULECTOMY WITH BREAST IMPLANT REMOVAL HAD BETTER OSP = 022 AND EFSP = 014 THAN DID PATIENTS WHO RECEIVED PARTIAL CAPSULECTOMY SYSTEMIC CHEMOTHERAPY OR RADIATION THERAPYÂ¿ CYTOLOGICAL MARKERS ALK- AND CD30+ HAVE BEEN REPORTED THERE IS CURRENTLY NO WAY TO DETERMINE WHICH CASES HAD WHICH THERAPIES OR DEVICE TYPE THIS REPORT WILL CAPTURE 37 UNREPORTED CASES OF ALCL  LYMPHOMA|UNK MAMMARY IMPLANT|UNK MAMMARY IMPLANT|12/07/2016||||*|*||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||NI|||||UNKNOWN MANUFACTURER|||||||True
6153112|61699206|D|1||LITERATURE ARTICLE Â¿BACTERIAL BIOFILM INFECTION DETECTED IN BREAST IMPLANT-ASSOCIATED ANAPLASTIC LARGE-CELL LYMPHOMAÂ¿ REPORTS Â¿TWENTY-SIX BREAST IMPLANTÂ¿ASSOCIATED ALCL SAMPLES WERE GATHERED FROM FOUR CENTERS FOR THIS INTERNATIONAL COLLABORATIVE STUDY FROM A TOTAL OF 22 PATIENTS TABLE 1Â¿ ARTICLE GOES ON TO STATE Â¿BOTH THE BREAST IMPLANTÂ¿ASSOCIATED ALCL AND NONTUMOR CAPSULE SAMPLES YIELDED HIGH MEAN NUMBERS OF BACTERIA BREAST IMPLANTÂ¿ASSOCIATED ALCL 47 Ã 106 CELLSMG OF TISSUE CAPSULE 49 Ã 106 CELLSMG OF TISSUE ANALYSIS OF THE MICROBIOME IN BREAST IMPLANTÂ¿ASSOCIATED ALCL SPECIMENS SHOWED SIGNIFICANT DIFFERENCES WITH SPECIES IDENTIFIED IN NONTUMOR CAPSULE SPECIMENS THERE WAS A SIGNIFICANTLY GREATER PROPORTION OF RALSTONIA SPP PRESENT IN ALCL SPECIMENS COMPARED WITH NONTUMOR CAPSULE SPECIMENS P  005 IN CONTRAST SIGNIFICANTLY MORE STAPHYLOCOCCUS SPP WERE FOUND ASSOCIATED WITH NONTUMOR CAPSULE SPECIMENS COMPARED WITH BREAST IMPLANTÂ¿ASSOCIATED ALCL SPECIMENS P  0001 BACTERIAL BIOFILM WAS VISUALIZED BOTH ON SCANNING ELECTRON MICROSCOPY AND FLUORESCENT IN SITU HYBRIDIZATIONÂ¿ CYTOLOGICAL MARKERS ALK- AND CD30+ HAVE BEEN REPORTED ARTICLE FURTHER STATES Â¿NONTUMOR CAPSULE SPECIMENS FROM 62 PATIENTS UNDERGOING REVISION SURGERY FOR HIGH-GRADE CAPSULAR CONTRACTUREÂ¿ THERE IS CURRENTLY NO WAY TO DETERMINE WHICH CASES HAD WHICH DEVICE TYPE THIS REPORT WILL CAPTURE 62 CASES OF NONTUMOR NON ALCL CAPSULAR CONTRACTURE|UNK MAMMARY IMPLANT|UNK MAMMARY IMPLANT|12/07/2016||||*|*||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||NI|||||UNKNOWN MANUFACTURER|||||||True
5672723|45694208|D|1||PHYSICIAN REPORTS PATIENT HAS BEEN DIAGNOSED WITH ANAPLASTIC LARGE CELL LYMPHOMA ALCL AT THE RIGHT BREAST IT CONCERNS A DIAGNOSE OF ALCL CD30+ AND ALK- FOLLOWING THE IDENTIFICATION OF PERIPROSTHETIC SEROMA WITH A BREAST IMPLANT THAT HAD BEEN IMPLANTED 10 YEAR AGO CAPSULECTOMY PERFORMED AND DEVICE EXPLANTED|STYLE 410 SILICONE GEL FILLED BREAST IMPLANT|ST-MM125-320|05/23/2016||||N|R||0HP|FTR|1.0|09/19/2010|PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||1139476|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN (COSTA RICA)|||||||True
6153076|61697271|D|1||LITERATURE ARTICLE Â¿BACTERIAL BIOFILM INFECTION DETECTED IN BREAST IMPLANT-ASSOCIATED ANAPLASTIC LARGE-CELL LYMPHOMAÂ¿ REPORTS Â¿TWENTY-SIX BREAST IMPLANTÂ¿ASSOCIATED ALCL SAMPLES WERE GATHERED FROM FOUR CENTERS FOR THIS INTERNATIONAL COLLABORATIVE STUDY FROM A TOTAL OF 22 PATIENTS TABLE 1Â¿ ARTICLE GOES ON TO STATE Â¿BOTH THE BREAST IMPLANTÂ¿ASSOCIATED ALCL AND NONTUMOR CAPSULE SAMPLES YIELDED HIGH MEAN NUMBERS OF BACTERIA BREAST IMPLANTÂ¿ASSOCIATED ALCL 47 Ã 106 CELLSMG OF TISSUE CAPSULE 49 Ã 106 CELLSMG OF TISSUE ANALYSIS OF THE MICROBIOME IN BREAST IMPLANTÂ¿ASSOCIATED ALCL SPECIMENS SHOWED SIGNIFICANT DIFFERENCES WITH SPECIES IDENTIFIED IN NONTUMOR CAPSULE SPECIMENS THERE WAS A SIGNIFICANTLY GREATER PROPORTION OF RALSTONIA SPP PRESENT IN ALCL SPECIMENS COMPARED WITH NONTUMOR CAPSULE SPECIMENS P  005 IN CONTRAST SIGNIFICANTLY MORE STAPHYLOCOCCUS SPP WERE FOUND ASSOCIATED WITH NONTUMOR CAPSULE SPECIMENS COMPARED WITH BREAST IMPLANTÂ¿ASSOCIATED ALCL SPECIMENS P  0001 BACTERIAL BIOFILM WAS VISUALIZED BOTH ON SCANNING ELECTRON MICROSCOPY AND FLUORESCENT IN SITU HYBRIDIZATIONÂ¿ CYTOLOGICAL MARKERS ALK- AND CD30+ HAVE BEEN REPORTED ARTICLE ADDITIONALLY REPORTS Â¿COMPARED WITH CLASSIC SYSTEMIC ALCL BREAST IMPLANTÂ¿ ASSOCIATED ALCL BEHAVES IN A MORE INDOLENT MANNER AND IS DIVIDED INTO PATHOLOGIC VARIETIES THE SEROMA-TYPE CONSISTING OF EFFUSIONS WITH AN ENCAPSULATING MARGIN OF CD30+ MALIGNANT LYMPHOCYTES THERE IS CURRENTLY NO WAY TO DETERMINE WHICH CASES HAD WHICH DEVICE TYPE OR TESTED NEGATIVE FOR BACTERIAL INFECTION THIS REPORT WILL CAPTURE 12 CASES OF ALCL WHICH PRESENTED AS EFFUSION|UNK MAMMARY IMPLANT|UNK MAMMARY IMPLANT|12/07/2016||||*|*||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||NI|||||UNKNOWN MANUFACTURER|||||||True
5793065|54159657|D|1||MEDICAL STAFF REPORTS ALCL RELATED TO THE IMPLANT ON THE RIGHT SIDE ACL CD30+ ALK NEGATIVE EXPLANT SURGERY CAPSULECTOMY AND SAMPLING OF PALPABLE NODULES IN THE AXILLARY TAIL OF THE RIGHT BREAST AND THE AXILLARY HOLLOW RIGHT NO BREAK PERI-PROSTHETIC SERUM DOUBLE CAPSULE YELLOWING OF THE IMPLANT FLUID OUTPOURING CITRINE AND CLOUDY APPEARANCE AND TISSUE DEPOSITS THE DEVICE HAS BEEN EXPLANTED THIS RECORD RELATES TO THE RIGHT SIDE|STYLE 410 COHESIVE SILICONE GEL FILLED BREAST IMPLANT|27-MM110-215|07/13/2016||01/06/2017|DA|R|Y||0HP|FTR|1.0|06/09/2012|PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||1445246|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN (COSTA RICA)|||||||True
5793065|69889264|D|1||MEDICAL STAFF REPORTS ALCL RELATED TO THE IMPLANT ON THE RIGHT SIDE ACL CD30+ ALK NEGATIVE EXPLANT SURGERY CAPSULECTOMY AND SAMPLING OF PALPABLE NODULES IN THE AXILLARY TAIL OF THE RIGHT BREAST AND THE AXILLARY HOLLOW RIGHT NO BREAK PERI-PROSTHETIC SERUM DOUBLE CAPSULE YELLOWING OF THE IMPLANT FLUID OUTPOURING CITRINE AND CLOUDY APPEARANCE AND TISSUE DEPOSITS THE DEVICE HAS BEEN EXPLANTED THIS RECORD RELATES TO THE RIGHT SIDE|STYLE 410 COHESIVE SILICONE GEL FILLED BREAST IMPLANT|27-MM110-215|07/13/2016||01/06/2017|DA|R|Y||0HP|FTR|1.0|06/09/2012|PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||1445246|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN (COSTA RICA)|||||||True
5793065|49492130|D|1||MEDICAL STAFF REPORTS ALCL RELATED TO THE IMPLANT ON THE RIGHT SIDE ACL CD30+ ALK NEGATIVE EXPLANT SURGERY CAPSULECTOMY AND SAMPLING OF PALPABLE NODULES IN THE AXILLARY TAIL OF THE RIGHT BREAST AND THE AXILLARY HOLLOW RIGHT NO BREAK PERI-PROSTHETIC SERUM DOUBLE CAPSULE YELLOWING OF THE IMPLANT FLUID OUTPOURING CITRINE AND CLOUDY APPEARANCE AND TISSUE DEPOSITS THE DEVICE HAS BEEN EXPLANTED THIS RECORD RELATES TO THE RIGHT SIDE|STYLE 410 COHESIVE SILICONE GEL FILLED BREAST IMPLANT|27-MM110-215|07/13/2016||01/06/2017|DA|R|Y||0HP|FTR|1.0|06/09/2012|PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||1445246|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN (COSTA RICA)|||||||True
5793065|68234084|D|1||MEDICAL STAFF REPORTS ALCL RELATED TO THE IMPLANT ON THE RIGHT SIDE ACL CD30+ ALK NEGATIVE EXPLANT SURGERY CASULECTOMY AND SAMPLING OF PALPABLE NODULES IN THE AXILLARY TAIL OF THE RIGHT BREAST AND THE AXILLARY HOLLOW RIGHT NO BREAK PERI-PROSTHETIC SERUM DOUBLE CAPSULE YELLOWING OF THE IMPLANT FLUID OUTPOURING CITRINE AND CLOUDY APPEARANCE AND TISSUE DEPOSITS THE DEVICE HAS BEEN EXPLANTED THIS RECORD RELATES TO THE RIGHT SIDE|STYLE 410 COHESIVE SILICONE GEL FILLED BREAST IMPLANT|27-MM110-215|07/13/2016||01/06/2017|DA|R|Y||0HP|FTR|1.0|06/09/2012|PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||1445246|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN (COSTA RICA)|||||||True
6139164|61260979|D|1||JOURNAL ARTICLE MARKED EOSINOPHILIA AS INITIAL PRESENTATION OF BREAST IMPLANT-ASSOCIATED ANAPLASTIC LARGE CELL LYMPHOMA REPORTS WE HERE DESCRIBE A CASE OF BI-ALCL IN A PATIENT WHO PRESENTED WITH HYPEREOSINOPHILIA AND DIFFUSE PRURITUS PATIENT PRESENTED WITH DISCOMFORT AND MODERATE PAIN IN THE LEFT BREAST AND A DIAGNOSIS OF CHRONIC SEROMA WAS MADE IN LEUKEMIA  LYMPHOMA 5711 2712-2715 DEVICE WAS REMOVED AND REPLACED WITH TEXTURED IMPLANT ALLERGAN PATIENTS SYMPTOMS PERSISTED AND THE REPLACEMENT IMPLANT WAS ALSO REMOVED ARTICLE STATES AS THE CHRONIC SEROMA CONTINUED A TRU-CUT BIOPSY WAS CARRIED OUT THREE YEARS LATER BUT ONLY REVEALED CHRONIC INFLAMMATIONÂ¿ ARTICLE GOES ON TO STATE A HISTOLOGICAL EXAMINATION OF THE PSEUDO-CAPSULE SHOWED THE DIFFUSE INFILTRATION OF LARGE CELLS WITH IRREGULAR ANAPLASTIC OR Â¿EMBRYO-LIKEÂ¿ NUCLEI AND AN ABUNDANT EOSINOPHILIC GRANULAR CYTOPLASM THE MALIGNANT POPULATION TESTED FOR CD30+ AND ALK-1 EXPRESSION AS BONE MARROW BIOPSY PERFORMED FOR STAGING PURPOSES WAS ALSO NEGATIVE A DIAGNOSIS OF BI-ALCL WAS MADE THIS FILE REPRESENTS THE DEVICE REMOVED PREVIOUS TO ALCL|UNK MAMMARY IMPLANT|UNK MAMMARY IMPLANT|12/01/2016||||N|R||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||NI|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN (COSTA RICA)|||||||True
6144474|61423059|D|1||REVIEWED JOURNAL ARTICLE Â¿WHOLE EXOME SEQUENCING REVEALS ACTIVATING JAK1 AND STAT3 MUTATIONS IN BREAST IMPLANT-ASSOCIATED ANAPLASTIC LARGE CELL LYMPHOMA ANAPLASTIC LARGE CELL LYMPHOMAÂ¿ IN JOURNAL HAEMATOLOGICA SEPTEMBER 2016 101 E387-E390 ARTICLE STATES PATIENT Â¿PRESENTED WITH A THREE MONTH HISTORY OF BREAST SWELLING APPROXIMATELY SEVEN YEARS AFTER INSERTION OF ANATOMIC SALT-LOSS TEXTURED SILICONE- FILLED BREAST IMPLANTS FLUID ASPIRATED FROM THE LEFT BREAST SHOWED LARGE ATYPICAL CELLS WHICH WERE CD2Â¿ CD3Â¿ CD4+ CD5+ CD7Â¿ CD8Â¿ CD30+ AND ALKÂ¿ BY IMMUNOHISTOCHEMISTRY HISTOLOGICAL EXAMINATION SHOWED DISEASE CONFINED TO THE EFFUSION WITH NO EVIDENCE OF INFILTRATION OF THE PSEUDOCAPSULE PATIENT UNDERWENT REMOVAL OF THE IMPLANT WITH NO OTHER LOCAL OR SYSTEMIC THERAPY AND REMAINS CLINICALLY WELL WITH NO EVIDENCE OF RECURRENCE AT SIX MONTHS FOLLOW-UPÂ¿|UNK GEL BREAST IMPLANT|UNK GEL BREAST IMPLANT|12/05/2016||||N|R||0HP|FTR|1.0||PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||NI|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN (COSTA RICA)|||||||True
6153092|61703507|D|1||LITERATURE ARTICLE Â¿BACTERIAL BIOFILM INFECTION DETECTED IN BREAST IMPLANT-ASSOCIATED ANAPLASTIC LARGE-CELL LYMPHOMAÂ¿ REPORTS Â¿TWENTY-SIX BREAST IMPLANTÂ¿ASSOCIATED ALCL SAMPLES WERE GATHERED FROM FOUR CENTERS FOR THIS INTERNATIONAL COLLABORATIVE STUDY FROM A TOTAL OF 22 PATIENTS TABLE 1Â¿ ARTICLE GOES ON TO STATE Â¿BOTH THE BREAST IMPLANTÂ¿ASSOCIATED ALCL AND NONTUMOR CAPSULE SAMPLES YIELDED HIGH MEAN NUMBERS OF BACTERIA BREAST IMPLANTÂ¿ASSOCIATED ALCL 47 Ã 106 CELLSMG OF TISSUE CAPSULE 49 Ã 106 CELLSMG OF TISSUE ANALYSIS OF THE MICROBIOME IN BREAST IMPLANTÂ¿ASSOCIATED ALCL SPECIMENS SHOWED SIGNIFICANT DIFFERENCES WITH SPECIES IDENTIFIED IN NONTUMOR CAPSULE SPECIMENS THERE WAS A SIGNIFICANTLY GREATER PROPORTION OF RALSTONIA SPP PRESENT IN ALCL SPECIMENS COMPARED WITH NONTUMOR CAPSULE SPECIMENS P  005 IN CONTRAST SIGNIFICANTLY MORE STAPHYLOCOCCUS SPP WERE FOUND ASSOCIATED WITH NONTUMOR CAPSULE SPECIMENS COMPARED WITH BREAST IMPLANTÂ¿ASSOCIATED ALCL SPECIMENS P  0001 BACTERIAL BIOFILM WAS VISUALIZED BOTH ON SCANNING ELECTRON MICROSCOPY AND FLUORESCENT IN SITU HYBRIDIZATIONÂ¿ CYTOLOGICAL MARKERS ALK- AND CD30+ HAVE BEEN REPORTED ARTICLE ADDITIONALLY REPORTS Â¿COMPARED WITH CLASSIC SYSTEMIC ALCL BREAST IMPLANTÂ¿ ASSOCIATED ALCL BEHAVES IN A MORE INDOLENT MANNER AND IS DIVIDED INTO PATHOLOGIC VARIETIESTHE LESS COMMON MASS-TYPE WITH A MORE CLINICALLY AGGRESSIVE INFILTRATING TUMORÂ¿ THERE IS CURRENTLY NO WAY TO DETERMINE WHICH CASES HAD WHICH DEVICE TYPE OR TESTED NEGATIVE FOR BACTERIAL INFECTION THIS REPORT WILL CAPTURE 5 CASES OF ALCL WHICH PRESENTED AS TUMOR MASS|UNK MAMMARY IMPLANT|UNK MAMMARY IMPLANT|12/07/2016||||*|*||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||NI|||||UNKNOWN MANUFACTURER|||||||True
6157808|62108428|D|1||LITERATURE ARTICLE Â¿COMPREHENSIVE IMMUNOPHENOTYPIC ANALYSIS OF 64 CASES OF BREAST IMPLANT-ASSOCIATED ANAPLASTIC LARGE CELL LYMPHOMA SHOWS AN ACTIVATED CYTOTOXIC WITH A SILENT T-CELL RECEPTOR PATTERNÂ¿ REPORTS Â¿64 CASESÂ¿ ARTICLE CONTINUES TO STATE Â¿WE REVIEWED THE WORLD LITERATURE FOR CASES OF BI-ALCL AND ACCRUED CASES IN WHICH IMMUNOPHENOTYPIC DATA DERIVED USING IMMUNOHISTOCHEMICAL OR FLOW CYTOMETRY METHODS WERE USED AND AT LEAST 5 OF THE FOLLOWING 13 MARKERS WERE REPORTED CD3 CD4 CD8 CD30 CD43 CD45 EMATIA-1 GRANZYME-B ALK-1 TCR-Â¿Â¿ AND TCR-GÂ¿ AND EBER IN SITU HYBRIDIZATION WHEN LESS THAN 5 MARKERS WERE REPORTED WE CONTACTED CORRESPONDING AUTHORS FOR AVAILABLE MATERIAL DID ADDITIONAL STUDIES AND INCLUDED THESE DATAÂ¿ Â¿CD30 WAS POSITIVE IN ALL N=64 CASES WHEREAS ALK AND EBER WERE NEGATIVE IN ALL TESTED CASES N=56 AND N=25 RESPECTIVELY CD3 WAS POSITIVE IN 15 OF 62 24 CASES CD4 4361 70 CD8 657 11 CD43 37 46 80 CD45 2949 59 EMA 2542 60 TIA-1 2846 61 GRANZYME-B 28 47 60 TCR Â¿Â¿ 5 24 21 AND TCR GÂ¿ IN 1 OF 23 4 THUS TCR WAS SILENT IN 1824 75 CASESÂ¿ CYTOLOGICAL MARKERS ALK- AND CD30+ HAVE BEEN REPORTED THIS RECORD HAS BEEN CREATED TO CAPTURE THE 56 CASES OF BREAST IMPLANT-ASSOCIATED ANAPLASTIC LARGE CELL LYMPHOMA|UNK MAMMARY IMPLANT|UNK MAMMARY IMPLANT|12/09/2016||||N|R||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||NI|||||UNKNOWN MANUFACTURER|||||||True
6153118|61701317|D|1||LITERATURE ARTICLE Â¿BACTERIAL BIOFILM INFECTION DETECTED IN BREAST IMPLANT-ASSOCIATED ANAPLASTIC LARGE-CELL LYMPHOMAÂ¿ REPORTS Â¿TWENTY-SIX BREAST IMPLANTÂ¿ASSOCIATED ALCL SAMPLES WERE GATHERED FROM FOUR CENTERS FOR THIS INTERNATIONAL COLLABORATIVE STUDY FROM A TOTAL OF 22 PATIENTS TABLE 1Â¿ ARTICLE GOES ON TO STATE Â¿BOTH THE BREAST IMPLANTÂ¿ASSOCIATED ALCL AND NONTUMOR CAPSULE SAMPLES YIELDED HIGH MEAN NUMBERS OF BACTERIA BREAST IMPLANTÂ¿ASSOCIATED ALCL 47 Ã 106 CELLSMG OF TISSUE CAPSULE 49 Ã 106 CELLSMG OF TISSUE ANALYSIS OF THE MICROBIOME IN BREAST IMPLANTÂ¿ASSOCIATED ALCL SPECIMENS SHOWED SIGNIFICANT DIFFERENCES WITH SPECIES IDENTIFIED IN NONTUMOR CAPSULE SPECIMENS THERE WAS A SIGNIFICANTLY GREATER PROPORTION OF RALSTONIA SPP PRESENT IN ALCL SPECIMENS COMPARED WITH NONTUMOR CAPSULE SPECIMENS P  005 IN CONTRAST SIGNIFICANTLY MORE STAPHYLOCOCCUS SPP WERE FOUND ASSOCIATED WITH NONTUMOR CAPSULE SPECIMENS COMPARED WITH BREAST IMPLANTÂ¿ASSOCIATED ALCL SPECIMENS P  0001 BACTERIAL BIOFILM WAS VISUALIZED BOTH ON SCANNING ELECTRON MICROSCOPY AND FLUORESCENT IN SITU HYBRIDIZATIONÂ¿ CYTOLOGICAL MARKERS ALK- AND CD30+ HAVE BEEN REPORTED ACCORDING TO TABLE 1 Â¿CLINICAL SUMMARY OF BREAST IMPLANTÂ¿ASSOCIATED ALCL PATIENTSÂ¿ THERE WAS 1 CASE OF ALCL PRESENT IN THE Â¿CAPSULEÂ¿ ARTICLE CLARIFIES THE Â¿CAPSULEÂ¿ CASE AS Â¿ONE PATIENT THE DIAGNOSIS OF BREAST IMPLANTÂ¿ASSOCIATED ALCL WAS AN INCIDENTAL FINDING WHILE UNDERGOING IMPLANT EXCHANGE FOR CAPSULAR CONTRACTUREÂ¿ THERE IS CURRENTLY NO WAY TO DETERMINE WHICH CASES HAD TESTED NEGATIVE FOR BACTERIAL INFECTION THIS REPORT WILL CAPTURE 1 CASE OF ALCL PRESENTED WITH Â¿CAPSULEÂ¿ REPRESENTED BY TERM CODE CAPSULAR CONTRACTURE|UNK MAMMARY IMPLANT|UNK MAMMARY IMPLANT|12/07/2016||||*|*||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||NI|||||UNKNOWN MANUFACTURER|||||||True
5440576|38326420|D|1||ALCL CASE REPORT WE REPORT THE CASE OF A B6 WOMAN SHE HAS PREVIOUS HISTORY OF SMOKING AND MULTIPLE BREAST AUGMENTATION SURGERIES WITH IMPLANTS THE FIRST ONE WAS 20 YEARS AGO THEN 15 YEARS AGO AND THE LAST WAS 3 YEARS AGO B6 2012 SHE DENIED ANY HISTORY OF ALLERGIC REACTION TRANSFUSION OR MEDICAL PROBLEMS SHE WAS TAKING ASPIRIN 81MG AT THE MOMENT OF THE EVENT SHE WAS ADMITTED TO THE HOSPITAL IN B6 2016 BECAUSE A 5 MONTH HISTORY OF PROGRESSIVE SWELLING OF THE RIGHT ARM ALSO SHE HAD AN ERYTHEMATOUS RASH ON HER ARM EXTENDING THROUGH THE CHEST AND RIGHT BREAST THE SKIN WAS INDURATED WITH A FIRM LUMP IN THE RIGHT EXTERNAL QUADRANT OF THE RIGHT BREAST SHE HAD PAIN ON HER ARM BUT SHE DIDNT HAVE FEVER WE ORDERED AN MRI OF THE ARM INVOLVING THE BREAST IT SHOWED A FASCIAL HYPERINTENSITY AND SWELLING OF THE SOFT TISSUE ADDITIONALLY WE PERFORMED ROUTINE LABORATORIES THAT SHOWED HYPERLEUKOCYTOSIS OF 38000 WITH SEVERE EOSINOPHILIA OF 26000 THE HAEMOGLOBIN AND PLATELETS WERE NORMAL THE HS-CRP WAS 292 AND THE PROCALCITONIN WAS NEGATIVE THE LDH WAS 393 AND THE BETA-2 MICROGLOBULIN WAS 2000 THE KIDNEY AND LIVER FUNCTION TEST WERE UNREMARKABLE WE PERFORMED A PET SCAN THAT SHOWED HYPERMETABOLISM OF THE PREVIOUS DESCRIBED SWOLLEN AREA AND ENLARGEMENT AND HYPERMETABOLISM OF PERIHEPATIC LYMPH NODES THEREFORE A BIOPSY OF THE ARM WAS PERFORMED THE PATHOLOGIC SPECIMEN INCLUDED SKIN SOFT TISSUE FASCIA AND MUSCLE THE PATHOLOGY RESULT WAS CONSISTENT WITH ANAPLASTIC LARGE CELL LYMPHOMA CD4+ CD30+ EMA+ ALT- SO A SURGICAL REMOVAL OF BOTH BREAST IMPLANTS WAS CARRIED OUT THE PATHOLOGY LAB CONFIRMED THAT AROUND THE IMPLANTS CAPSULE OF THE RIGHT BREAST WAS AN EXTENDED INFILTRATION OF NEOPLASTIC CELLS CONSISTENT WITH ANAPLASTIC LARGE CELL LYMPHOMA WITH THE SAME IMMUNOHISTOCHEMISTRY PROFILE INTERESTINGLY THE NEOPLASTIC CELLS WERE SURROUNDED BY AN EOSINOPHIL-RICH INFLAMMATORY INFILTRATE THE LEFT IMPLANT DIDNT HAVE NEOPLASTIC CELLS THE IMPLANTS WERE ALLERGAN MODEL MHP WITH A VOLUME OF 130 CUBIC CENTIMETERS THEY WERE ROUND AND FILLED BY COHESIVE SILICONE CURRENTLY THE PT IS UNDER SYSTEMIC CHEMOTHERAPY WITH CYCLOPHOSPHAMIDE DOXORUBICIN ETOPOSIDE VINCRISTINE AND PREDNISONE|ALLERGAN SILICONE BREAST IMPLANT||02/11/2016||||*|*||0HP|FTR|1.0||ALLERGAN SILICONE BREAST IMPLANT||||||US|ALLERGAN|||||MHP||True
5440576|38326420|D|1||ALCL CASE REPORT WE REPORT THE CASE OF A B6 WOMAN SHE HAS PREVIOUS HISTORY OF SMOKING AND MULTIPLE BREAST AUGMENTATION SURGERIES WITH IMPLANTS THE FIRST ONE WAS 20 YEARS AGO THEN 15 YEARS AGO AND THE LAST WAS 3 YEARS AGO B6 2012 SHE DENIED ANY HISTORY OF ALLERGIC REACTION TRANSFUSION OR MEDICAL PROBLEMS SHE WAS TAKING ASPIRIN 81MG AT THE MOMENT OF THE EVENT SHE WAS ADMITTED TO THE HOSPITAL IN B6 2016 BECAUSE A 5 MONTH HISTORY OF PROGRESSIVE SWELLING OF THE RIGHT ARM ALSO SHE HAD AN ERYTHEMATOUS RASH ON HER ARM EXTENDING THROUGH THE CHEST AND RIGHT BREAST THE SKIN WAS INDURATED WITH A FIRM LUMP IN THE RIGHT EXTERNAL QUADRANT OF THE RIGHT BREAST SHE HAD PAIN ON HER ARM BUT SHE DIDNT HAVE FEVER WE ORDERED AN MRI OF THE ARM INVOLVING THE BREAST IT SHOWED A FASCIAL HYPERINTENSITY AND SWELLING OF THE SOFT TISSUE ADDITIONALLY WE PERFORMED ROUTINE LABORATORIES THAT SHOWED HYPERLEUKOCYTOSIS OF 38000 WITH SEVERE EOSINOPHILIA OF 26000 THE HAEMOGLOBIN AND PLATELETS WERE NORMAL THE HS-CRP WAS 292 AND THE PROCALCITONIN WAS NEGATIVE THE LDH WAS 393 AND THE BETA-2 MICROGLOBULIN WAS 2000 THE KIDNEY AND LIVER FUNCTION TEST WERE UNREMARKABLE WE PERFORMED A PET SCAN THAT SHOWED HYPERMETABOLISM OF THE PREVIOUS DESCRIBED SWOLLEN AREA AND ENLARGEMENT AND HYPERMETABOLISM OF PERIHEPATIC LYMPH NODES THEREFORE A BIOPSY OF THE ARM WAS PERFORMED THE PATHOLOGIC SPECIMEN INCLUDED SKIN SOFT TISSUE FASCIA AND MUSCLE THE PATHOLOGY RESULT WAS CONSISTENT WITH ANAPLASTIC LARGE CELL LYMPHOMA CD4+ CD30+ EMA+ ALT- SO A SURGICAL REMOVAL OF BOTH BREAST IMPLANTS WAS CARRIED OUT THE PATHOLOGY LAB CONFIRMED THAT AROUND THE IMPLANTS CAPSULE OF THE RIGHT BREAST WAS AN EXTENDED INFILTRATION OF NEOPLASTIC CELLS CONSISTENT WITH ANAPLASTIC LARGE CELL LYMPHOMA WITH THE SAME IMMUNOHISTOCHEMISTRY PROFILE INTERESTINGLY THE NEOPLASTIC CELLS WERE SURROUNDED BY AN EOSINOPHIL-RICH INFLAMMATORY INFILTRATE THE LEFT IMPLANT DIDNT HAVE NEOPLASTIC CELLS THE IMPLANTS WERE ALLERGAN MODEL MHP WITH A VOLUME OF 130 CUBIC CENTIMETERS THEY WERE ROUND AND FILLED BY COHESIVE SILICONE CURRENTLY THE PT IS UNDER SYSTEMIC CHEMOTHERAPY WITH CYCLOPHOSPHAMIDE DOXORUBICIN ETOPOSIDE VINCRISTINE AND PREDNISONE|ALLERGAN SILICONE BREAST IMPLANT||02/11/2016||||*|*||0HP|FTR|2.0||ALLERGAN SILICONE BREAST IMPLANT||||||US|ALLERGAN|||||MHP||True
6153187|61697756|D|1||LITERATURE ARTICLE Â¿BACTERIAL BIOFILM INFECTION DETECTED IN BREAST IMPLANT-ASSOCIATED ANAPLASTIC LARGE-CELL LYMPHOMAÂ¿ REPORTS Â¿TWENTY-SIX BREAST IMPLANTÂ¿ASSOCIATED ALCL SAMPLES WERE GATHERED FROM FOUR CENTERS FOR THIS INTERNATIONAL COLLABORATIVE STUDY FROM A TOTAL OF 22 PATIENTS TABLE 1Â¿ ARTICLE GOES ON TO STATE Â¿BOTH THE BREAST IMPLANTÂ¿ASSOCIATED ALCL AND NONTUMOR CAPSULE SAMPLES YIELDED HIGH MEAN NUMBERS OF BACTERIA BREAST IMPLANTÂ¿ASSOCIATED ALCL 47 Ã 106 CELLSMG OF TISSUE CAPSULE 49 Ã 106 CELLSMG OF TISSUE ANALYSIS OF THE MICROBIOME IN BREAST IMPLANTÂ¿ASSOCIATED ALCL SPECIMENS SHOWED SIGNIFICANT DIFFERENCES WITH SPECIES IDENTIFIED IN NONTUMOR CAPSULE SPECIMENS THERE WAS A SIGNIFICANTLY GREATER PROPORTION OF RALSTONIA SPP PRESENT IN ALCL SPECIMENS COMPARED WITH NONTUMOR CAPSULE SPECIMENS P  005 IN CONTRAST SIGNIFICANTLY MORE STAPHYLOCOCCUS SPP WERE FOUND ASSOCIATED WITH NONTUMOR CAPSULE SPECIMENS COMPARED WITH BREAST IMPLANTÂ¿ASSOCIATED ALCL SPECIMENS P  0001 BACTERIAL BIOFILM WAS VISUALIZED BOTH ON SCANNING ELECTRON MICROSCOPY AND FLUORESCENT IN SITU HYBRIDIZATIONÂ¿ CYTOLOGICAL MARKERS ALK- AND CD30+ HAVE BEEN REPORTED ACCORDING TO TABLE 1 Â¿CLINICAL SUMMARY OF BREAST IMPLANTÂ¿ASSOCIATED ALCL PATIENTSÂ¿ THERE WAS 1 CASE OF ALCL WHICH PRESENTED WITH BOTH EFFUSION AND TUMOR THERE IS CURRENTLY NO WAY TO DETERMINE WHICH CASES HAD WHICH DEVICE TYPE OR TESTED NEGATIVE FOR BACTERIAL INFECTION THIS REPORT WILL CAPTURE 1 CASE OF ALCL WHICH PRESENTED WITH BOTH EFFUSION AND TUMOR|UNK MAMMARY IMPLANT|UNK MAMMARY IMPLANT|12/07/2016||||*|*||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||NI|||||UNKNOWN MANUFACTURER|||||||True
5697379|46493993|D|1||THE FOLLOWING JOURNAL ARTICLE WAS REVIEWED Â¿BREAST IMPLANTÂ¿ASSOCIATED ANAPLASTIC LARGE CELL LYMPHOMA REPORT OF 2 CASES AND REVIEW OF THE LITERATUREÂ¿ THE AUTHORS REPORTED THAT A PATIENT HAD UNDERGONE BILATERAL BREAST AUGMENTATION 16 YEARS EARLIER 425-CC TEXTURED ROUND SALINE IMPLANTS WERE PLACED SUBGLANDULARLY THE MANUFACTURER OF THE IMPLANTS WAS NOT KNOWN PATIENT PRESENTED WITH ACUTE ENLARGEMENT OF THE RIGHT BREAST ULTRASONOGRAPHY SHOWED A FLUID COLLECTION AROUND THE RIGHT INTACT BREAST IMPLANT ULTRASOUND-GUIDED FLUID ASPIRATION SHOWED CD30+ ALKÂ¿ ALCL THE CELLS WERE POSITIVE FOR CD45 CD5 CD4 BUT FAILED TO EXPRESS CD34 CD20 CD68 OR CD10 THE PATIENT UNDERWENT BILATERAL CAPSULECTOMIES AND IMPLANT REMOVAL APPROXIMATELY TWO MONTHS AFTER PRESENTATION IMMEDIATELY AFTER REMOVAL THE IMPLANTS AND CAPSULES WERE EXAMINED FOR MALIGNANCY FLOW CYTOMETRY CYTOGENETIC ANALYSIS AND IMMUNOHISTOCHEMICAL STAINING FAILED TO IDENTIFY ANY UNIQUE CELL POPULATIONS THE PATIENT DID NOT RECEIVE ANY ADDITIONAL TREATMENT AND WAS FREE OF DISEASE AT PATIENTS 15-MONTH FOLLOW-UP VISIT PATIENT CONTINUES TO BE MONITORED CLOSELY BECAUSE OF CHRONIC PAIN IN THE AFFECTED BREASTÂ¿|UNK SALINE IMPLANT|UNK SALINE IMPLANT|06/03/2016||||N|R||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||NI|||||UNKNOWN MANUFACTURER|||||||True
